Add files using upload-large-folder tool
Browse files- CT/lung2/data/raw/gdc/clinical/14c25e4a-b585-42ab-a158-a79a474a37cc/nationwidechildrens.org_clinical.TCGA-DB-A4XD.xml +194 -0
- CT/lung2/data/raw/gdc/clinical/14cef899-429e-42a7-ab52-bc4b36cddf18/nationwidechildrens.org_clinical.TCGA-DH-5142.xml +283 -0
- CT/lung2/data/raw/gdc/clinical/14e37af9-ee6f-4b0e-a0f4-3bf704085d85/nationwidechildrens.org_clinical.TCGA-WY-A85D.xml +111 -0
- CT/lung2/data/raw/gdc/clinical/15c392fc-ad4d-450e-84fd-1b4237a3a2be/nationwidechildrens.org_clinical.TCGA-P5-A5F0.xml +252 -0
- CT/lung2/data/raw/gdc/clinical/15cbed64-def3-485b-a118-49551c5dc58f/nationwidechildrens.org_clinical.TCGA-HT-7476.xml +223 -0
- CT/lung2/data/raw/gdc/clinical/15dfbefe-3639-4316-bd76-97c25d57e6a8/nationwidechildrens.org_clinical.TCGA-TM-A84G.xml +164 -0
- CT/lung2/data/raw/gdc/clinical/15eba653-b395-425e-8a64-92491f9beba9/TCGA-HT-7467.440FCE7D-5D39-4E81-8B2D-11726CBD3481.PDF +0 -0
- CT/lung2/data/raw/gdc/clinical/1658af63-4a94-4c20-8457-e7e37ef57e41/nationwidechildrens.org_clinical.TCGA-VM-A8CF.xml +214 -0
- CT/lung2/data/raw/gdc/clinical/168db80f-2f72-4091-9e9d-e5caaaa09b02/nationwidechildrens.org_clinical.TCGA-DB-A64W.xml +194 -0
- CT/lung2/data/raw/gdc/clinical/16dd1089-ea5f-4796-ab30-66b29f5fef6d/nationwidechildrens.org_clinical.TCGA-HT-7482.xml +225 -0
- CT/lung2/data/raw/gdc/clinical/16f991ff-06a0-4070-9388-a09491afb091/nationwidechildrens.org_clinical.TCGA-QH-A65R.xml +194 -0
- CT/lung2/data/raw/gdc/clinical/1724c4ed-1da9-4675-8786-79e69ef7bada/TCGA-IK-7675.BB5FC5DF-BC8D-4603-A924-C2CBE7CD2E7D.PDF +0 -0
- CT/lung2/data/raw/gdc/clinical/17d951e7-5dc9-4da6-8c2a-add42f6057ff/nationwidechildrens.org_clinical.TCGA-QH-A6CZ.xml +143 -0
- CT/lung2/data/raw/gdc/clinical/186eaec9-46f1-43ab-b7eb-afca51fcfbf9/nationwidechildrens.org_clinical.TCGA-S9-A6U0.xml +341 -0
- CT/lung2/data/raw/gdc/clinical/18dbac67-e2b7-42f8-9317-b070b710303b/nationwidechildrens.org_clinical.TCGA-QH-A6CV.xml +184 -0
- CT/lung2/data/raw/gdc/clinical/18eba95f-6cba-4125-a771-8e5d6107bb3d/nationwidechildrens.org_clinical.TCGA-S9-A6TS.xml +252 -0
- CT/lung2/data/raw/gdc/clinical/190d2fa6-a8ee-49f7-9bab-4babaf3da73d/nationwidechildrens.org_omf.TCGA-DU-A76O.xml +70 -0
- CT/lung2/data/raw/gdc/clinical/191c5c43-b7f4-4b16-9710-024180600d88/TCGA-P5-A735.7950CF04-F8C0-4855-A108-BB15B1B65B0D.PDF +0 -0
- CT/lung2/data/raw/gdc/clinical/1922985c-8b0f-4b69-bf0c-109823e200b8/nationwidechildrens.org_clinical.TCGA-HT-8106.xml +143 -0
- CT/lung2/data/raw/gdc/clinical/1984e470-74ee-4d4e-8b76-d97ab7f83308/nationwidechildrens.org_clinical.TCGA-DU-A76L.xml +249 -0
CT/lung2/data/raw/gdc/clinical/14c25e4a-b585-42ab-a158-a79a474a37cc/nationwidechildrens.org_clinical.TCGA-DB-A4XD.xml
ADDED
|
@@ -0,0 +1,194 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">0E90BEBF-397D-4514-99E9-1EB91FEDC3F3</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">292.66.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412845">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412846">Astrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412860">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412853">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412887">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-11741</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">822</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412858">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DB-A4XD</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">DB</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A4XD</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">1BFF1E07-4923-43D5-B2D3-CB46B6568EED</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412861">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.2</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9401/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.2</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412851">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412852">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">32</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412864">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412865">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412896">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">21</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412859">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412916"/>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412921">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412849">Supratentorial, Temporal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412847">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412850">Cerebral Cortex</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412866">NO</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412848">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412867">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412868">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412869">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412870">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412871">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412872"/>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412873">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412874">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412875">YES</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2412876"/>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2412877"/>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412878"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2412879"/>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412880"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412881"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2412882"/>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412883"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412884"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412885">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412886">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412907">NO</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412908">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412909">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412910"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412911"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412912">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412913"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Evaluated" restricted="false" source_system_identifier="2412914"/>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Evaluated" restricted="false" source_system_identifier="2412915"/>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412922">YES</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412923">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412924">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412929"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412934"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412941"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412942"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412975">NO</rx:tx_on_clinical_trial>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DB-A4XD-D40472</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">031BBEB5-469C-4856-AB64-13746690D8E2</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">24</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">291</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412978">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412976">Temodar</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2412977"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412983">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412988">Complete Response</clin_shared:measure_of_response>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">21</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
</rx:drugs>
|
| 138 |
+
<rad:radiations>
|
| 139 |
+
<rad:radiation>
|
| 140 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DB-A4XD-R40473</rad:bcr_radiation_barcode>
|
| 141 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">53B6D106-00D6-420C-8694-BB3C2D1749DD</rad:bcr_radiation_uuid>
|
| 142 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">24</rad:days_to_radiation_therapy_start>
|
| 143 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">69</rad:days_to_radiation_therapy_end>
|
| 144 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412992">External</rad:radiation_type>
|
| 145 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 146 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412994">5890</rad:radiation_dosage>
|
| 147 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412995">cGy</rad:units>
|
| 148 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412996">31</rad:numfractions>
|
| 149 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2412993">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 150 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 151 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 152 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2413001">NO</rad:radiation_treatment_ongoing>
|
| 153 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 154 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2413006">Stable Disease</clin_shared:measure_of_response>
|
| 155 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">21</clin_shared:day_of_form_completion>
|
| 156 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:month_of_form_completion>
|
| 157 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 158 |
+
</rad:radiation>
|
| 159 |
+
</rad:radiations>
|
| 160 |
+
<lgg:follow_ups>
|
| 161 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 162 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DB-A4XD-F60950</clin_shared:bcr_followup_barcode>
|
| 163 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">D94A5C65-553F-4D10-BACF-88FBB58FD04A</clin_shared:bcr_followup_uuid>
|
| 164 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665663">NO</clin_shared:lost_follow_up>
|
| 165 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665687">Alive</clin_shared:vital_status>
|
| 166 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665666">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 167 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">1210</clin_shared:days_to_last_followup>
|
| 168 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665697">NO</nte:new_tumor_event_after_initial_treatment>
|
| 170 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 171 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3665702"/>
|
| 172 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 173 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665696">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 174 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 176 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3665713"/>
|
| 177 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3665712"/>
|
| 178 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">19</clin_shared:day_of_form_completion>
|
| 179 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 180 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 181 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665662">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 182 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 183 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 184 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 185 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665714">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 186 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665665">YES</clin_shared:postoperative_rx_tx>
|
| 187 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3665664">YES</clin_shared:radiation_therapy>
|
| 188 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 189 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3665707"/>
|
| 190 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 191 |
+
</follow_up_v1.0:follow_up>
|
| 192 |
+
</lgg:follow_ups>
|
| 193 |
+
</lgg:patient>
|
| 194 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/14cef899-429e-42a7-ab52-bc4b36cddf18/nationwidechildrens.org_clinical.TCGA-DH-5142.xml
ADDED
|
@@ -0,0 +1,283 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">0ACE7738-1F1B-475B-822B-0D475E268B11</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">78.87.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517873">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517874">Astrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517885">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517879">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517918">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-10678</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">922</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517883">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DH-5142</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">DH</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">5142</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">5b744051-7355-4e15-b035-0621e709a5d7</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517889">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9401/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518634">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518635">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">29</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517888">2008</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517890">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517919">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517626">8</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517625">12</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517627">2010</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517884">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518633">Pre-Adjuvant Therapy</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517877">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517875">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517878">Cerebral Cortex</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517891">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517876">Left</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517892">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517893">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517894">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517895">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517896">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517897">Seizures</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517898">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517899">YES</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517900">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517901">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517902">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="517903"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517904">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="517905"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="517906"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517907">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="517908"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="517909"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517910">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="517911">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518624"/>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518625"/>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518626">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518627"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518628"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518629"/>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518630"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518631">90</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518632">0</clin_shared:eastern_cancer_oncology_group>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">10</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518915">2</rx:regimen_number>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DH-5142-D6544</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">91998a7d-11c1-427d-b99b-db9ef95ed478</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518924">1800</rx:total_dose>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518925">mg</rx:total_dose_units>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518922">360</rx:prescribed_dose>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518923">mg/day</rx:prescribed_dose_units>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518921">1</rx:number_cycles>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">89</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">93</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518918">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518919"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518920">Temozolomide</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518916">ADJUVANT</clin_shared:regimen_indication>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="518917"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518926">PO</rx:route_of_administration>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518930">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518913">20</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518912">12</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518914">2010</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
<rx:drug>
|
| 138 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 139 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518891">1</rx:regimen_number>
|
| 140 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DH-5142-D6543</rx:bcr_drug_barcode>
|
| 141 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">b983b0e5-76b1-4c94-90ec-c9f65f430202</rx:bcr_drug_uuid>
|
| 142 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518900">2400</rx:total_dose>
|
| 143 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518901">mg/m2</rx:total_dose_units>
|
| 144 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518898">75</rx:prescribed_dose>
|
| 145 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518899">mg/m2/day</rx:prescribed_dose_units>
|
| 146 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518897">1</rx:number_cycles>
|
| 147 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">21</rx:days_to_drug_therapy_start>
|
| 148 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">52</rx:days_to_drug_therapy_end>
|
| 149 |
+
<rx:therapy_types>
|
| 150 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518894">Chemotherapy</rx:therapy_type>
|
| 151 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518895"/>
|
| 152 |
+
</rx:therapy_types>
|
| 153 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518896">Temozolomide</rx:drug_name>
|
| 154 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 155 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518892">ADJUVANT</clin_shared:regimen_indication>
|
| 156 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="518893"/>
|
| 157 |
+
<rx:route_of_administrations>
|
| 158 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518902">PO</rx:route_of_administration>
|
| 159 |
+
</rx:route_of_administrations>
|
| 160 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518906">NO</rx:therapy_ongoing>
|
| 161 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 162 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518844">20</clin_shared:day_of_form_completion>
|
| 163 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518843">12</clin_shared:month_of_form_completion>
|
| 164 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518845">2010</clin_shared:year_of_form_completion>
|
| 165 |
+
</rx:drug>
|
| 166 |
+
<rx:drug>
|
| 167 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 168 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518939">3</rx:regimen_number>
|
| 169 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DH-5142-D6545</rx:bcr_drug_barcode>
|
| 170 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">9111add0-24dc-4c01-9713-7daf44bd49a3</rx:bcr_drug_uuid>
|
| 171 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518948">5280</rx:total_dose>
|
| 172 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518949">mg</rx:total_dose_units>
|
| 173 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518946">480</rx:prescribed_dose>
|
| 174 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518947">mg/day</rx:prescribed_dose_units>
|
| 175 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518945">11</rx:number_cycles>
|
| 176 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">117</rx:days_to_drug_therapy_start>
|
| 177 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">400</rx:days_to_drug_therapy_end>
|
| 178 |
+
<rx:therapy_types>
|
| 179 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518942">Chemotherapy</rx:therapy_type>
|
| 180 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518943"/>
|
| 181 |
+
</rx:therapy_types>
|
| 182 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518944">Temozolomide</rx:drug_name>
|
| 183 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 184 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518940">ADJUVANT</clin_shared:regimen_indication>
|
| 185 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="518941"/>
|
| 186 |
+
<rx:route_of_administrations>
|
| 187 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518950">PO</rx:route_of_administration>
|
| 188 |
+
</rx:route_of_administrations>
|
| 189 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518954">NO</rx:therapy_ongoing>
|
| 190 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 191 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518937">20</clin_shared:day_of_form_completion>
|
| 192 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518936">12</clin_shared:month_of_form_completion>
|
| 193 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518938">2010</clin_shared:year_of_form_completion>
|
| 194 |
+
</rx:drug>
|
| 195 |
+
</rx:drugs>
|
| 196 |
+
<rad:radiations>
|
| 197 |
+
<rad:radiation>
|
| 198 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DH-5142-R6541</rad:bcr_radiation_barcode>
|
| 199 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">f6f74ced-0454-4887-b0eb-f5e2288b46b3</rad:bcr_radiation_uuid>
|
| 200 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">21</rad:days_to_radiation_therapy_start>
|
| 201 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">52</rad:days_to_radiation_therapy_end>
|
| 202 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518817">EXTERNAL BEAM</rad:radiation_type>
|
| 203 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="518818"/>
|
| 204 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518820">4920</rad:radiation_dosage>
|
| 205 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518821">cGy</rad:units>
|
| 206 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518822">41</rad:numfractions>
|
| 207 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518819">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 208 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518815">ADJUVANT</clin_shared:regimen_indication>
|
| 209 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518816"/>
|
| 210 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518826">NO</rad:radiation_treatment_ongoing>
|
| 211 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518814">1</rad:course_number>
|
| 212 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 213 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518739">17</clin_shared:day_of_form_completion>
|
| 214 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518738">12</clin_shared:month_of_form_completion>
|
| 215 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518740">2010</clin_shared:year_of_form_completion>
|
| 216 |
+
</rad:radiation>
|
| 217 |
+
</rad:radiations>
|
| 218 |
+
<lgg:follow_ups>
|
| 219 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 220 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DH-5142-F6539</clin_shared:bcr_followup_barcode>
|
| 221 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">80691eab-fcc9-4041-95b5-85b111b17bd1</clin_shared:bcr_followup_uuid>
|
| 222 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 223 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518650">Alive</clin_shared:vital_status>
|
| 224 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518643">Stable Disease</clin_shared:primary_therapy_outcome_success>
|
| 225 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">922</clin_shared:days_to_last_followup>
|
| 226 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 227 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518655">NO</nte:new_tumor_event_after_initial_treatment>
|
| 228 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 229 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518659"/>
|
| 230 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 231 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518651">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 232 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 233 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 234 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518719"/>
|
| 235 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518718"/>
|
| 236 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518639">8</clin_shared:day_of_form_completion>
|
| 237 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518638">12</clin_shared:month_of_form_completion>
|
| 238 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518640">2010</clin_shared:year_of_form_completion>
|
| 239 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 240 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518712">90</clin_shared:karnofsky_performance_score>
|
| 241 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518713">0</clin_shared:eastern_cancer_oncology_group>
|
| 242 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518714">Pre-Adjuvant Therapy</clin_shared:performance_status_scale_timing>
|
| 243 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518720">Stable Disease</clin_shared:followup_treatment_success>
|
| 244 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518642">YES</clin_shared:postoperative_rx_tx>
|
| 245 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="518641">YES</clin_shared:radiation_therapy>
|
| 246 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 247 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="518663"/>
|
| 248 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 249 |
+
</follow_up_v1.0:follow_up>
|
| 250 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 251 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DH-5142-F66689</clin_shared:bcr_followup_barcode>
|
| 252 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">69870580-2062-412B-9F1E-5369310C1A7E</clin_shared:bcr_followup_uuid>
|
| 253 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926216">YES</clin_shared:lost_follow_up>
|
| 254 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926220">Alive</clin_shared:vital_status>
|
| 255 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926219">Stable Disease</clin_shared:primary_therapy_outcome_success>
|
| 256 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">1943</clin_shared:days_to_last_followup>
|
| 257 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 258 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926493">YES</nte:new_tumor_event_after_initial_treatment>
|
| 259 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000">1627</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 260 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926498">NO</nte:additional_surgery_locoregional_procedure>
|
| 261 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 262 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926229">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 263 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 264 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 265 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926512">YES</nte:additional_pharmaceutical_therapy>
|
| 266 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926511">NO</nte:additional_radiation_therapy>
|
| 267 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">22</clin_shared:day_of_form_completion>
|
| 268 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 269 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 270 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926215">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 271 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 272 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 273 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 274 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3926513"/>
|
| 275 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926218">YES</clin_shared:postoperative_rx_tx>
|
| 276 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3926217">YES</clin_shared:radiation_therapy>
|
| 277 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 278 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3926503"/>
|
| 279 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 280 |
+
</follow_up_v1.0:follow_up>
|
| 281 |
+
</lgg:follow_ups>
|
| 282 |
+
</lgg:patient>
|
| 283 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/14e37af9-ee6f-4b0e-a0f4-3bf704085d85/nationwidechildrens.org_clinical.TCGA-WY-A85D.xml
ADDED
|
@@ -0,0 +1,111 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">34D4B8A6-C356-4E3C-BFB9-3B8D36348EB5</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">368.45.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460499">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460500">Oligoastrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460514">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460507">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460541">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-21979</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">1147</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460512">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-WY-A85D</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">WY</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A85D</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">0D5A4C63-C3FB-4295-A433-D90CDBFC4ED6</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460515">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9382/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460505">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460506">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">60</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460518">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460519">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460550">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3460513"/>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460607"/>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460612">NO</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460503">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460501">G2</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460504">Not listed in Medical Record</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460520">NO</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460502">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460521">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460522">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460523">YES</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460524">YES</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460525">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460526">Sensory Changes</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460527">> 181 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460528">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460529">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460530">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460531">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460532"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460533">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460534"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460535"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460536">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460537"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460538"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460539">YES</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460540">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460598">YES</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460599">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460600">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460601"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460602"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460603">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460604"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460605"/>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460606">1</clin_shared:eastern_cancer_oncology_group>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460613">NO</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460614">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460707">YES</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000">887</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460712"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000">922</nte:days_to_additional_surgery_locoregional_procedure>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3460717"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460781">YES</nte:additional_radiation_therapy>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460782">YES</nte:additional_pharmaceutical_therapy>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs/>
|
| 108 |
+
<rad:radiations/>
|
| 109 |
+
<lgg:follow_ups/>
|
| 110 |
+
</lgg:patient>
|
| 111 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/15c392fc-ad4d-450e-84fd-1b4237a3a2be/nationwidechildrens.org_clinical.TCGA-P5-A5F0.xml
ADDED
|
@@ -0,0 +1,252 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">E9601A0D-9AD1-4C62-801F-04E7D0659149</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">295.65.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909030">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909031">Oligodendroglioma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909045">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909038">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909072">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-12157</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">125</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909043">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-P5-A5F0</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">P5</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A5F0</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">7EB5D055-E1C8-4B93-9205-A49A6E79DFD4</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909046">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.9</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9450/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.9</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909036">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909037">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">33</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909049">2012</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909050">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909081">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909044">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2909091"/>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909096">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909034">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909032">G2</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909035">Not listed in Medical Record</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909051">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909033">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909052">YES</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909053">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909054">YES</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909055">YES</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909056">YES</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909057">Seizures</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909058">> 181 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909059">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909060">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909061">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909062">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909063"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2909064"/>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909065"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909066"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2909067"/>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909068"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909069"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909070">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909071">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2909082"/>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2909083"/>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909084">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909085"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909086"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909087">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909088"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909089">80</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2909090"/>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909097">YES</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2909098"/>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2909099">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909104"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909109"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909114"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2909115"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446301">NO</rx:tx_on_clinical_trial>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-P5-A5F0-D56613</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">23BCC949-2852-41F4-BDAF-D4952D034C99</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">89</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">287</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446304">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446302">Lomustine</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3446303"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446309">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446314">Partial Response</clin_shared:measure_of_response>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
<rx:drug>
|
| 138 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583574">NO</rx:tx_on_clinical_trial>
|
| 139 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 140 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-P5-A5F0-D59339</rx:bcr_drug_barcode>
|
| 141 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">805459C3-71F0-4B2F-A213-299DB0870A26</rx:bcr_drug_uuid>
|
| 142 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 143 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 144 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 145 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 146 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 147 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">89</rx:days_to_drug_therapy_start>
|
| 148 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">287</rx:days_to_drug_therapy_end>
|
| 149 |
+
<rx:therapy_types>
|
| 150 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583577">Chemotherapy</rx:therapy_type>
|
| 151 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 152 |
+
</rx:therapy_types>
|
| 153 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583575">Vincristine</rx:drug_name>
|
| 154 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3583576"/>
|
| 155 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 156 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 157 |
+
<rx:route_of_administrations>
|
| 158 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 159 |
+
</rx:route_of_administrations>
|
| 160 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583582">NO</rx:therapy_ongoing>
|
| 161 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583587">Partial Response</clin_shared:measure_of_response>
|
| 162 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:day_of_form_completion>
|
| 163 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:month_of_form_completion>
|
| 164 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 165 |
+
</rx:drug>
|
| 166 |
+
<rx:drug>
|
| 167 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583591">NO</rx:tx_on_clinical_trial>
|
| 168 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 169 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-P5-A5F0-D59340</rx:bcr_drug_barcode>
|
| 170 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">BBF4D2E7-E9D8-4C79-ABF5-15A7A8699D7C</rx:bcr_drug_uuid>
|
| 171 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 172 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 173 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 174 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 176 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">89</rx:days_to_drug_therapy_start>
|
| 177 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">287</rx:days_to_drug_therapy_end>
|
| 178 |
+
<rx:therapy_types>
|
| 179 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583594">Chemotherapy</rx:therapy_type>
|
| 180 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 181 |
+
</rx:therapy_types>
|
| 182 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583592">Procarbazine</rx:drug_name>
|
| 183 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3583593"/>
|
| 184 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 185 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 186 |
+
<rx:route_of_administrations>
|
| 187 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 188 |
+
</rx:route_of_administrations>
|
| 189 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583599">NO</rx:therapy_ongoing>
|
| 190 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3583604">Partial Response</clin_shared:measure_of_response>
|
| 191 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:day_of_form_completion>
|
| 192 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:month_of_form_completion>
|
| 193 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 194 |
+
</rx:drug>
|
| 195 |
+
</rx:drugs>
|
| 196 |
+
<rad:radiations>
|
| 197 |
+
<rad:radiation>
|
| 198 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-P5-A5F0-R56612</rad:bcr_radiation_barcode>
|
| 199 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">2C6D0A9F-D4A0-4CE8-AE17-78A61256F79C</rad:bcr_radiation_uuid>
|
| 200 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">23</rad:days_to_radiation_therapy_start>
|
| 201 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">70</rad:days_to_radiation_therapy_end>
|
| 202 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446283">External</rad:radiation_type>
|
| 203 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 204 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446285">60</rad:radiation_dosage>
|
| 205 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446286">Gy</rad:units>
|
| 206 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3446287"/>
|
| 207 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446284">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 208 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 209 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 210 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446292">NO</rad:radiation_treatment_ongoing>
|
| 211 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 212 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3446297">Partial Response</clin_shared:measure_of_response>
|
| 213 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:day_of_form_completion>
|
| 214 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:month_of_form_completion>
|
| 215 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 216 |
+
</rad:radiation>
|
| 217 |
+
</rad:radiations>
|
| 218 |
+
<lgg:follow_ups>
|
| 219 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 220 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-P5-A5F0-F69045</clin_shared:bcr_followup_barcode>
|
| 221 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">5FF200EA-CC7D-41B7-82F0-6814B7181D40</clin_shared:bcr_followup_uuid>
|
| 222 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4035299">NO</clin_shared:lost_follow_up>
|
| 223 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4035303">Alive</clin_shared:vital_status>
|
| 224 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4035302">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 225 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">287</clin_shared:days_to_last_followup>
|
| 226 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 227 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="4035313"/>
|
| 228 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 229 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4035318"/>
|
| 230 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 231 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Discrepancy" restricted="false" source_system_identifier="4035312" xsi:nil="true"/>
|
| 232 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 233 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 234 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4035329"/>
|
| 235 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4035328"/>
|
| 236 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">24</clin_shared:day_of_form_completion>
|
| 237 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 238 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 239 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4035298">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 240 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 241 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 242 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 243 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="4035330" xsi:nil="true"/>
|
| 244 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4035301">YES</clin_shared:postoperative_rx_tx>
|
| 245 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4035300">YES</clin_shared:radiation_therapy>
|
| 246 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 247 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4035323"/>
|
| 248 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 249 |
+
</follow_up_v1.0:follow_up>
|
| 250 |
+
</lgg:follow_ups>
|
| 251 |
+
</lgg:patient>
|
| 252 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/15cbed64-def3-485b-a118-49551c5dc58f/nationwidechildrens.org_clinical.TCGA-HT-7476.xml
ADDED
|
@@ -0,0 +1,223 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">6D476273-74DC-4AC6-8871-87FFA92CA427</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">163.82.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544144">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544145">Astrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544156">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544150">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544183">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-9614</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">199</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544154">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7476</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">HT</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">7476</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">27d0d3cb-16c0-4ba8-9662-95917f665004</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544160">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9400/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544224">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544225">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">26</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544159">2011</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544161">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544190">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544114">7</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544113">2</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544115">2012</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544155">HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544220"/>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544148">Supratentorial, Temporal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544146">G2</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544149">Cerebral Cortex</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544162">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544147">Left</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544163">YES</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544164">YES</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544165">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544166">YES</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544167">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544168">Seizures</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544169">31 - 90 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544170">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544171">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544172">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544173">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544174"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544175">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544176"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544177"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544178">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544179"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544180"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544181">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544182">YES</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544211">YES</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544212">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544213">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544214"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544215"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544216">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544217"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544218"/>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544219"/>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544395">2</rx:regimen_number>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7476-D21244</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">7b368f14-efc6-449e-a680-2b1dacafae06</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544404">1400</rx:total_dose>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544405">mg</rx:total_dose_units>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544402">280</rx:prescribed_dose>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544403">mg/day</rx:prescribed_dose_units>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544401">3</rx:number_cycles>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">118</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544398">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544399"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544400">temodar</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544396">ADJUVANT</clin_shared:regimen_indication>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1544397"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544406">PO</rx:route_of_administration>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544410">YES</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544393">7</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544392">2</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544394">2012</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
<rx:drug>
|
| 138 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 139 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544371">1</rx:regimen_number>
|
| 140 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7476-D21243</rx:bcr_drug_barcode>
|
| 141 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">1087cef3-36cb-4992-ad47-390efd05380e</rx:bcr_drug_uuid>
|
| 142 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544380">4200</rx:total_dose>
|
| 143 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544381">mg</rx:total_dose_units>
|
| 144 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544378">140</rx:prescribed_dose>
|
| 145 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544379">mg/day</rx:prescribed_dose_units>
|
| 146 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544377">1</rx:number_cycles>
|
| 147 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">41</rx:days_to_drug_therapy_start>
|
| 148 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">80</rx:days_to_drug_therapy_end>
|
| 149 |
+
<rx:therapy_types>
|
| 150 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544374">Chemotherapy</rx:therapy_type>
|
| 151 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544375"/>
|
| 152 |
+
</rx:therapy_types>
|
| 153 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544376">temodar</rx:drug_name>
|
| 154 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 155 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544372">ADJUVANT</clin_shared:regimen_indication>
|
| 156 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1544373"/>
|
| 157 |
+
<rx:route_of_administrations>
|
| 158 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544382">PO</rx:route_of_administration>
|
| 159 |
+
</rx:route_of_administrations>
|
| 160 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544386">NO</rx:therapy_ongoing>
|
| 161 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 162 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544369">7</clin_shared:day_of_form_completion>
|
| 163 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544368">2</clin_shared:month_of_form_completion>
|
| 164 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544370">2012</clin_shared:year_of_form_completion>
|
| 165 |
+
</rx:drug>
|
| 166 |
+
</rx:drugs>
|
| 167 |
+
<rad:radiations>
|
| 168 |
+
<rad:radiation>
|
| 169 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7476-R21241</rad:bcr_radiation_barcode>
|
| 170 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">f5197e34-b55f-4791-8416-7861a4b4786c</rad:bcr_radiation_uuid>
|
| 171 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">41</rad:days_to_radiation_therapy_start>
|
| 172 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">80</rad:days_to_radiation_therapy_end>
|
| 173 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544348">EXTERNAL BEAM</rad:radiation_type>
|
| 174 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1544349"/>
|
| 175 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544351">5400</rad:radiation_dosage>
|
| 176 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544352">cGy</rad:units>
|
| 177 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544353">30</rad:numfractions>
|
| 178 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544350">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 179 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544346">ADJUVANT</clin_shared:regimen_indication>
|
| 180 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544347"/>
|
| 181 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544357">NO</rad:radiation_treatment_ongoing>
|
| 182 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544345">1</rad:course_number>
|
| 183 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 184 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544343">7</clin_shared:day_of_form_completion>
|
| 185 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544342">2</clin_shared:month_of_form_completion>
|
| 186 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544344">2012</clin_shared:year_of_form_completion>
|
| 187 |
+
</rad:radiation>
|
| 188 |
+
</rad:radiations>
|
| 189 |
+
<lgg:follow_ups>
|
| 190 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 191 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7476-F21240</clin_shared:bcr_followup_barcode>
|
| 192 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">b458719d-93c2-4787-8cc4-d347621d3f46</clin_shared:bcr_followup_uuid>
|
| 193 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 194 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544287">Alive</clin_shared:vital_status>
|
| 195 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544239">Stable Disease</clin_shared:primary_therapy_outcome_success>
|
| 196 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">199</clin_shared:days_to_last_followup>
|
| 197 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 198 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544295">NO</nte:new_tumor_event_after_initial_treatment>
|
| 199 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 200 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544299"/>
|
| 201 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 202 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544294">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 203 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 204 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 205 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544338"/>
|
| 206 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544337"/>
|
| 207 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544234">7</clin_shared:day_of_form_completion>
|
| 208 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544233">2</clin_shared:month_of_form_completion>
|
| 209 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544235">2012</clin_shared:year_of_form_completion>
|
| 210 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544236">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 211 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544334"/>
|
| 212 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544335"/>
|
| 213 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544336"/>
|
| 214 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544339"/>
|
| 215 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544238">YES</clin_shared:postoperative_rx_tx>
|
| 216 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1544237">YES</clin_shared:radiation_therapy>
|
| 217 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 218 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1544303"/>
|
| 219 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 220 |
+
</follow_up_v1.0:follow_up>
|
| 221 |
+
</lgg:follow_ups>
|
| 222 |
+
</lgg:patient>
|
| 223 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/15dfbefe-3639-4316-bd76-97c25d57e6a8/nationwidechildrens.org_clinical.TCGA-TM-A84G.xml
ADDED
|
@@ -0,0 +1,164 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">A2E31BFF-E027-45A5-9DDC-CE5E00B83D0A</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">368.45.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439316">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439317">Oligodendroglioma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439331">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439324">FEMALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439358">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-20014</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">1045</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439329">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-TM-A84G</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">TM</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A84G</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">63F4AA26-DEC0-4309-8B75-6446A7241527</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439332">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9451/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439322">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439323">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">54</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439335">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439336">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439367">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">17</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439330">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439377">Preoperative</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439382">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439320">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439318">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439321">Not listed in Medical Record</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439337">NO</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439319">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439338">YES</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439339">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439340">YES</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439341">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439342">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439343">Headaches</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439344">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439345">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439346">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439347">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439348">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439349"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439350">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439351"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439352"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439353">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439354"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439355"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3439356"/>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3439357"/>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439368">NO</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439369">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439370">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439371"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439372"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3439373"/>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439374"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439375">100</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439376">0</clin_shared:eastern_cancer_oncology_group>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">0</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439383">NO</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439384">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439385">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439390"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439395"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439400"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3439401"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs/>
|
| 108 |
+
<rad:radiations>
|
| 109 |
+
<rad:radiation>
|
| 110 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-TM-A84G-R56470</rad:bcr_radiation_barcode>
|
| 111 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">6CD89CD7-37A1-4F68-AB8F-835A5AEEDF86</rad:bcr_radiation_uuid>
|
| 112 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">63</rad:days_to_radiation_therapy_start>
|
| 113 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">105</rad:days_to_radiation_therapy_end>
|
| 114 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439405">External</rad:radiation_type>
|
| 115 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 116 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439407">60</rad:radiation_dosage>
|
| 117 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439408">Gy</rad:units>
|
| 118 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439409">30</rad:numfractions>
|
| 119 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439406">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 120 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 121 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 122 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439414">NO</rad:radiation_treatment_ongoing>
|
| 123 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 124 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3439419">Complete Response</clin_shared:measure_of_response>
|
| 125 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">17</clin_shared:day_of_form_completion>
|
| 126 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:month_of_form_completion>
|
| 127 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 128 |
+
</rad:radiation>
|
| 129 |
+
</rad:radiations>
|
| 130 |
+
<lgg:follow_ups>
|
| 131 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 132 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-TM-A84G-F65394</clin_shared:bcr_followup_barcode>
|
| 133 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">7B7538D1-BA60-4CF3-8792-7F94039ED93A</clin_shared:bcr_followup_uuid>
|
| 134 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870379">NO</clin_shared:lost_follow_up>
|
| 135 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870383">Alive</clin_shared:vital_status>
|
| 136 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870382">Complete Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 137 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">1236</clin_shared:days_to_last_followup>
|
| 138 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 139 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870393">NO</nte:new_tumor_event_after_initial_treatment>
|
| 140 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 141 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3870398"/>
|
| 142 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 143 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870392">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 144 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 145 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 146 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3870409"/>
|
| 147 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3870408"/>
|
| 148 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">23</clin_shared:day_of_form_completion>
|
| 149 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9</clin_shared:month_of_form_completion>
|
| 150 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 151 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870378">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 152 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 153 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 154 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 155 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870410">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 156 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870381">NO</clin_shared:postoperative_rx_tx>
|
| 157 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3870380">YES</clin_shared:radiation_therapy>
|
| 158 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 159 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3870403"/>
|
| 160 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 161 |
+
</follow_up_v1.0:follow_up>
|
| 162 |
+
</lgg:follow_ups>
|
| 163 |
+
</lgg:patient>
|
| 164 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/15eba653-b395-425e-8a64-92491f9beba9/TCGA-HT-7467.440FCE7D-5D39-4E81-8B2D-11726CBD3481.PDF
ADDED
|
Binary file (10.7 kB). View file
|
|
|
CT/lung2/data/raw/gdc/clinical/1658af63-4a94-4c20-8457-e7e37ef57e41/nationwidechildrens.org_clinical.TCGA-VM-A8CF.xml
ADDED
|
@@ -0,0 +1,214 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">0AC0DFC4-6614-4CCF-8060-33EF1CA491E9</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">368.45.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401799">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401800">Astrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401814">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401807">FEMALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401841">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-16334</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">294</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401812">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-VM-A8CF</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">VM</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A8CF</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">0073A136-D5F4-4FD6-88F9-711768F2ABC6</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401815">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9401/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401805">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401806">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">44</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401818">2013</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401819">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401850">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">14</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">1</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3401813"/>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401903">Pre-Adjuvant Therapy</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401908">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401803">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401801">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401804">Not listed in Medical Record</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401820">NO</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401802">Left</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401821">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401822">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401823">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401824">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401825">YES</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401826">Motor/Movement Changes</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401827">> 181 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3401828"/>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3401829"/>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3401830"/>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3401831"/>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401832"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3401833"/>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401834"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401835"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3401836"/>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401837"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401838"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401839">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401840">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401894">NO</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401895">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401896">YES</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401897">IHC</lgg:ldh1_mutation_test_method>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401898">YES</lgg:ldh1_mutation_found>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401899">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401900"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401901">60</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Evaluated" restricted="false" source_system_identifier="3401902"/>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">26</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401909">NO</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3401910"/>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3401911">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401916"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401921"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401926"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3401927"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3572828">NO</rx:tx_on_clinical_trial>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-VM-A8CF-D56941</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">6AF8B596-1900-4064-83A0-438EF1CC6731</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">41</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">88</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3572831">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3572829">Temodar</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3572830"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3572836">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3572841">Stable Disease</clin_shared:measure_of_response>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">30</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">4</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
</rx:drugs>
|
| 138 |
+
<rad:radiations>
|
| 139 |
+
<rad:radiation>
|
| 140 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-VM-A8CF-R56936</rad:bcr_radiation_barcode>
|
| 141 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">7BBA7F69-915E-45DA-9B0F-440EC5EC7A61</rad:bcr_radiation_uuid>
|
| 142 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">42</rad:days_to_radiation_therapy_start>
|
| 143 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">81</rad:days_to_radiation_therapy_end>
|
| 144 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460840">External</rad:radiation_type>
|
| 145 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 146 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460842">5040</rad:radiation_dosage>
|
| 147 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460843">cGy</rad:units>
|
| 148 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460844">28</rad:numfractions>
|
| 149 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460841">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 150 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 151 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 152 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460849">NO</rad:radiation_treatment_ongoing>
|
| 153 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 154 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460854">Stable Disease</clin_shared:measure_of_response>
|
| 155 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 156 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:month_of_form_completion>
|
| 157 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 158 |
+
</rad:radiation>
|
| 159 |
+
<rad:radiation>
|
| 160 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-VM-A8CF-R56940</rad:bcr_radiation_barcode>
|
| 161 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">0B9D92BC-0B07-48B5-B85D-645F3CB467B1</rad:bcr_radiation_uuid>
|
| 162 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">82</rad:days_to_radiation_therapy_start>
|
| 163 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">88</rad:days_to_radiation_therapy_end>
|
| 164 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460905">External</rad:radiation_type>
|
| 165 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 166 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460907">900</rad:radiation_dosage>
|
| 167 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460908">cGy</rad:units>
|
| 168 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460909">5</rad:numfractions>
|
| 169 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460906">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 170 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 171 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 172 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460914">NO</rad:radiation_treatment_ongoing>
|
| 173 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 174 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3460919">Stable Disease</clin_shared:measure_of_response>
|
| 175 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 176 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:month_of_form_completion>
|
| 177 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 178 |
+
</rad:radiation>
|
| 179 |
+
</rad:radiations>
|
| 180 |
+
<lgg:follow_ups>
|
| 181 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 182 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-VM-A8CF-F66857</clin_shared:bcr_followup_barcode>
|
| 183 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">F2EEC069-0622-4000-AA45-164C54A37387</clin_shared:bcr_followup_uuid>
|
| 184 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3935553">NO</clin_shared:lost_follow_up>
|
| 185 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3935557">Alive</clin_shared:vital_status>
|
| 186 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3935556"/>
|
| 187 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">609</clin_shared:days_to_last_followup>
|
| 188 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 189 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3935567">NO</nte:new_tumor_event_after_initial_treatment>
|
| 190 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 191 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3935572"/>
|
| 192 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 193 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3935566">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 194 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 195 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 196 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3935583"/>
|
| 197 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3935582"/>
|
| 198 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">24</clin_shared:day_of_form_completion>
|
| 199 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 200 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 201 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3935552">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 202 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 203 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 204 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 205 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3935584">Stable Disease</clin_shared:followup_treatment_success>
|
| 206 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3935555">YES</clin_shared:postoperative_rx_tx>
|
| 207 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3935554">YES</clin_shared:radiation_therapy>
|
| 208 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 209 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3935577"/>
|
| 210 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 211 |
+
</follow_up_v1.0:follow_up>
|
| 212 |
+
</lgg:follow_ups>
|
| 213 |
+
</lgg:patient>
|
| 214 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/168db80f-2f72-4091-9e9d-e5caaaa09b02/nationwidechildrens.org_clinical.TCGA-DB-A64W.xml
ADDED
|
@@ -0,0 +1,194 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">3A34FB25-169F-4147-B1F2-55F5002ADEDC</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">306.60.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778990">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778991">Oligoastrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779005">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778998">FEMALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779032">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-23936</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">415</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779003">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DB-A64W</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">DB</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A64W</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">DF22BC30-96E2-42DE-9A39-2954DB49841D</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779006">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9382/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778996">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778997">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">65</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779009">2012</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779010">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779041">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779004">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779051">Preoperative</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779056">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778994">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778992">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778995">Cerebral Cortex</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779011">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2778993">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779012">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779013">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779014">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779015">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779016">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779017">Seizures</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779018">> 181 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779019">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779020">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2779021"/>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2779022"/>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779023"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2779024"/>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779025"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779026"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2779027"/>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779028"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779029"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779030">YES</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779031">YES</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2779042"/>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2779043"/>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779044">YES</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779045">IHC</lgg:ldh1_mutation_test_method>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779046">YES</lgg:ldh1_mutation_found>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779047">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779048"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779049">90</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Evaluated" restricted="false" source_system_identifier="2779050"/>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">-20</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779057">YES</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779058">Stable Disease</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779059">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779064"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779069"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779074"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779075"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779121">NO</rx:tx_on_clinical_trial>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DB-A64W-D46509</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">07E285BC-D322-4AB9-8083-F1F3F64A2814</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">34</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">274</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779124">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779122">Temodar</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2779123"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779129">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779134">Stable Disease</clin_shared:measure_of_response>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
</rx:drugs>
|
| 138 |
+
<rad:radiations>
|
| 139 |
+
<rad:radiation>
|
| 140 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DB-A64W-R46508</rad:bcr_radiation_barcode>
|
| 141 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">649811CF-0CB8-40D3-91D6-E2B58EADD1AA</rad:bcr_radiation_uuid>
|
| 142 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">34</rad:days_to_radiation_therapy_start>
|
| 143 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">79</rad:days_to_radiation_therapy_end>
|
| 144 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779079">External</rad:radiation_type>
|
| 145 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 146 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779081">5940</rad:radiation_dosage>
|
| 147 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779082">cGy</rad:units>
|
| 148 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779083">33</rad:numfractions>
|
| 149 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779080">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 150 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 151 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 152 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779088">NO</rad:radiation_treatment_ongoing>
|
| 153 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 154 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2779093">Stable Disease</clin_shared:measure_of_response>
|
| 155 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:day_of_form_completion>
|
| 156 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 157 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 158 |
+
</rad:radiation>
|
| 159 |
+
</rad:radiations>
|
| 160 |
+
<lgg:follow_ups>
|
| 161 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 162 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DB-A64W-F62623</clin_shared:bcr_followup_barcode>
|
| 163 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">D3CB1ABF-C616-4FFA-905C-9AAD4DF98857</clin_shared:bcr_followup_uuid>
|
| 164 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749694">NO</clin_shared:lost_follow_up>
|
| 165 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749698">Dead</clin_shared:vital_status>
|
| 166 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749697">Stable Disease</clin_shared:primary_therapy_outcome_success>
|
| 167 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Not Available" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000"/>
|
| 168 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Completed" preferred_name="death_days_to" display_order="54" cde_ver="1.000">438</clin_shared:days_to_death>
|
| 169 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749708">NO</nte:new_tumor_event_after_initial_treatment>
|
| 170 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 171 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3749713"/>
|
| 172 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 173 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749707">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 174 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 176 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3749724"/>
|
| 177 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3749723"/>
|
| 178 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">22</clin_shared:day_of_form_completion>
|
| 179 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">7</clin_shared:month_of_form_completion>
|
| 180 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 181 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749693">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 182 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 183 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 184 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 185 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749725">Stable Disease</clin_shared:followup_treatment_success>
|
| 186 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749696">YES</clin_shared:postoperative_rx_tx>
|
| 187 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3749695">YES</clin_shared:radiation_therapy>
|
| 188 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 189 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3749718"/>
|
| 190 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 191 |
+
</follow_up_v1.0:follow_up>
|
| 192 |
+
</lgg:follow_ups>
|
| 193 |
+
</lgg:patient>
|
| 194 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/16dd1089-ea5f-4796-ab30-66b29f5fef6d/nationwidechildrens.org_clinical.TCGA-HT-7482.xml
ADDED
|
@@ -0,0 +1,225 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">23DD4F94-3733-4468-B5B3-6733DB0A9EFF</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">163.82.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542870">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542871">Oligoastrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542882">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542876">FEMALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542909">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-6857</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">1644</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542880">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7482</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">HT</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">7482</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">448d3e3b-622c-4e79-bb1d-b5f2e92970e8</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542886">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.9</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9382/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.9</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542930">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542931">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">18</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542885">2005</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542887">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542916">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542821">6</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542820">2</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542822">2012</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542881">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542926"/>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542874">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542872">G2</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542875">Not listed in Medical Record</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542888">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542873">Left</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542889">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542890">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542891">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542892">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542893">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542894">Seizures</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542895">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542896">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542897">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542898">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542899">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542900"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542901">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542902"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542903"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542904">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542905"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542906"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542907">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542908">YES</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542917">NO</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542918">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542919">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542920"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542921"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1542922">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542923"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542924"/>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1542925"/>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805102">1</rx:regimen_number>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7482-D29533</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">5e15e3a1-af84-4651-a196-a1b6efb3969a</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805111">18500</rx:total_dose>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805112">mg</rx:total_dose_units>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805109">370</rx:prescribed_dose>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805110">mg/day</rx:prescribed_dose_units>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805108">10</rx:number_cycles>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">577</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="month" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">853</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805105">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1805106"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805107">Temodar</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805103">PROGRESSION</clin_shared:regimen_indication>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1805104"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805113">PO</rx:route_of_administration>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805117">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805100">9</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805099">3</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805101">2012</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
</rx:drugs>
|
| 138 |
+
<rad:radiations>
|
| 139 |
+
<rad:radiation>
|
| 140 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7482-R29534</rad:bcr_radiation_barcode>
|
| 141 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">e4485cf5-4dbc-4374-8030-989d981cab37</rad:bcr_radiation_uuid>
|
| 142 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">405</rad:days_to_radiation_therapy_start>
|
| 143 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">447</rad:days_to_radiation_therapy_end>
|
| 144 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805129">EXTERNAL BEAM</rad:radiation_type>
|
| 145 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="1805130"/>
|
| 146 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805132">5400</rad:radiation_dosage>
|
| 147 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805133">cGy</rad:units>
|
| 148 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805134">30</rad:numfractions>
|
| 149 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805131">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 150 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805127">ADJUVANT</clin_shared:regimen_indication>
|
| 151 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1805128"/>
|
| 152 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805138">NO</rad:radiation_treatment_ongoing>
|
| 153 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805126">1</rad:course_number>
|
| 154 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 155 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805124">9</clin_shared:day_of_form_completion>
|
| 156 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805123">3</clin_shared:month_of_form_completion>
|
| 157 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805125">2012</clin_shared:year_of_form_completion>
|
| 158 |
+
</rad:radiation>
|
| 159 |
+
</rad:radiations>
|
| 160 |
+
<lgg:follow_ups>
|
| 161 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 162 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7482-F29532</clin_shared:bcr_followup_barcode>
|
| 163 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">94431290-31f7-4884-adda-8c93aa2cef26</clin_shared:bcr_followup_uuid>
|
| 164 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 165 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805068">Alive</clin_shared:vital_status>
|
| 166 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805067">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 167 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">1826</clin_shared:days_to_last_followup>
|
| 168 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805076">YES</nte:new_tumor_event_after_initial_treatment>
|
| 170 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000">374</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 171 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805080">YES</nte:additional_surgery_locoregional_procedure>
|
| 172 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000">377</nte:days_to_additional_surgery_locoregional_procedure>
|
| 173 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805075">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 174 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 176 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805095">YES</nte:additional_pharmaceutical_therapy>
|
| 177 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805094">YES</nte:additional_radiation_therapy>
|
| 178 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805062">9</clin_shared:day_of_form_completion>
|
| 179 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805061">3</clin_shared:month_of_form_completion>
|
| 180 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805063">2012</clin_shared:year_of_form_completion>
|
| 181 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805064">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 182 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805088">90</clin_shared:karnofsky_performance_score>
|
| 183 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1805089"/>
|
| 184 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805090">Post-Adjuvant Therapy</clin_shared:performance_status_scale_timing>
|
| 185 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805096">Partial Remission/Response</clin_shared:followup_treatment_success>
|
| 186 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805066">NO</clin_shared:postoperative_rx_tx>
|
| 187 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1805065">YES</clin_shared:radiation_therapy>
|
| 188 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">388</clin_shared:days_to_performance_status_assessment>
|
| 189 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1805084"/>
|
| 190 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 191 |
+
</follow_up_v1.0:follow_up>
|
| 192 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 193 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-7482-F66423</clin_shared:bcr_followup_barcode>
|
| 194 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">A88A864D-8460-42DD-BF38-2303157EB899</clin_shared:bcr_followup_uuid>
|
| 195 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912868">NO</clin_shared:lost_follow_up>
|
| 196 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912872">Alive</clin_shared:vital_status>
|
| 197 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912871">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 198 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">3253</clin_shared:days_to_last_followup>
|
| 199 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 200 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912882">YES</nte:new_tumor_event_after_initial_treatment>
|
| 201 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000">374</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 202 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912887">YES</nte:additional_surgery_locoregional_procedure>
|
| 203 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000">377</nte:days_to_additional_surgery_locoregional_procedure>
|
| 204 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912881">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 205 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 206 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 207 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912898">NO</nte:additional_pharmaceutical_therapy>
|
| 208 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912897">NO</nte:additional_radiation_therapy>
|
| 209 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">14</clin_shared:day_of_form_completion>
|
| 210 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 211 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 212 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912867">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 213 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 214 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 215 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 216 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912899">Complete Remission/Response</clin_shared:followup_treatment_success>
|
| 217 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912870">YES</clin_shared:postoperative_rx_tx>
|
| 218 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3912869">YES</clin_shared:radiation_therapy>
|
| 219 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 220 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3912892"/>
|
| 221 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 222 |
+
</follow_up_v1.0:follow_up>
|
| 223 |
+
</lgg:follow_ups>
|
| 224 |
+
</lgg:patient>
|
| 225 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/16f991ff-06a0-4070-9388-a09491afb091/nationwidechildrens.org_clinical.TCGA-QH-A65R.xml
ADDED
|
@@ -0,0 +1,194 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">E6428BE1-1BCC-4191-AA7D-D7B5C9B5F2D3</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">319.55.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742194">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742195">Oligodendroglioma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742209">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742202">FEMALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742236">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-14073</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">175</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742207">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A65R</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">QH</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A65R</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">505E9812-D13E-42D3-AEE2-55A85D6F4551</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742210">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.9</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9451/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.9</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742200">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742201">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">38</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742213">2013</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742214">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742245">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742208">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742310">Preoperative</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742353">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742198">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742196">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742199">White Matter</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742215">NO</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742197">Left</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742216">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742217">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742218">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742219">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742220">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742221"/>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742222"/>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742223">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742224">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742225">YES</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742226">YES</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742227">< 12 Years</lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742228">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742229"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742230"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742231">YES</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742232">CAT</lgg:animal_insect_allergy_types>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742233">> 20 Years</lgg:first_diagnosis_age_of_animal_insect_allergy>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742234">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742235">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742301">YES</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742302">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742303">YES</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742304">IHC</lgg:ldh1_mutation_test_method>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742305">YES</lgg:ldh1_mutation_found>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742306">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742307"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742308">100</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742309">0</clin_shared:eastern_cancer_oncology_group>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">-10</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742354">YES</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742355">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2742356">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742361"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742366"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742371"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2742372"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762116">NO</rx:tx_on_clinical_trial>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A65R-D46271</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">2B190C17-1558-498E-B160-A6E7434F0D02</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">32</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">430</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762119">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762117">TEMOZOLOMIDE</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2762118"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762124">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762129">Stable Disease</clin_shared:measure_of_response>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
</rx:drugs>
|
| 138 |
+
<rad:radiations>
|
| 139 |
+
<rad:radiation>
|
| 140 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A65R-R46275</rad:bcr_radiation_barcode>
|
| 141 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">53AD1607-2E46-4B95-B036-503A24ADCA4D</rad:bcr_radiation_uuid>
|
| 142 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">32</rad:days_to_radiation_therapy_start>
|
| 143 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">69</rad:days_to_radiation_therapy_end>
|
| 144 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762201">External</rad:radiation_type>
|
| 145 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 146 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762203">52</rad:radiation_dosage>
|
| 147 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762204">Gy</rad:units>
|
| 148 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762205">26</rad:numfractions>
|
| 149 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762202">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 150 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 151 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 152 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762210">NO</rad:radiation_treatment_ongoing>
|
| 153 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 154 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2762215">Stable Disease</clin_shared:measure_of_response>
|
| 155 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:day_of_form_completion>
|
| 156 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 157 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 158 |
+
</rad:radiation>
|
| 159 |
+
</rad:radiations>
|
| 160 |
+
<lgg:follow_ups>
|
| 161 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 162 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A65R-F59571</clin_shared:bcr_followup_barcode>
|
| 163 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">0FE6ACFC-9A2B-49F6-9EAF-DB1F644290C7</clin_shared:bcr_followup_uuid>
|
| 164 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596108">NO</clin_shared:lost_follow_up>
|
| 165 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596112">Alive</clin_shared:vital_status>
|
| 166 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596111">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 167 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">461</clin_shared:days_to_last_followup>
|
| 168 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 169 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596122">NO</nte:new_tumor_event_after_initial_treatment>
|
| 170 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 171 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3596127"/>
|
| 172 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 173 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596121">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 174 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 176 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3596138"/>
|
| 177 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3596137"/>
|
| 178 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:day_of_form_completion>
|
| 179 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 180 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 181 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596107">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 182 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 183 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 184 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 185 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596139">Stable Disease</clin_shared:followup_treatment_success>
|
| 186 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596110">YES</clin_shared:postoperative_rx_tx>
|
| 187 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3596109">YES</clin_shared:radiation_therapy>
|
| 188 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 189 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3596132"/>
|
| 190 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 191 |
+
</follow_up_v1.0:follow_up>
|
| 192 |
+
</lgg:follow_ups>
|
| 193 |
+
</lgg:patient>
|
| 194 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/1724c4ed-1da9-4675-8786-79e69ef7bada/TCGA-IK-7675.BB5FC5DF-BC8D-4603-A924-C2CBE7CD2E7D.PDF
ADDED
|
Binary file (17.6 kB). View file
|
|
|
CT/lung2/data/raw/gdc/clinical/17d951e7-5dc9-4da6-8c2a-add42f6057ff/nationwidechildrens.org_clinical.TCGA-QH-A6CZ.xml
ADDED
|
@@ -0,0 +1,143 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">BD7214BB-5CE1-44E5-91C6-870EBDA094E9</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">329.54.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746542">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746543">Oligoastrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746557">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746550">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746584">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-14007</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">96</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746555">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A6CZ</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">QH</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A6CZ</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">B4F4C9B5-BC50-4F35-A7DA-FD011C3B2C02</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746558">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9382/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746548">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746549">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">38</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746561">2013</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746562">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746593">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746556">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746603">Preoperative</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746608">NO</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746546">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746544">G2</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746547">White Matter</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746563">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746545">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746564">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746565">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746566">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746567">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746568">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746569">Seizures</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746570">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746571">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746572">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746573">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746574">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746575"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746576">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746577"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746578"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746579">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746580"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746581"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746582">YES</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746583">YES</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746594">NO</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746595">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746596">YES</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746597">IHC</lgg:ldh1_mutation_test_method>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746598">YES</lgg:ldh1_mutation_found>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2746599"/>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746600"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746601">90</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746602">1</clin_shared:eastern_cancer_oncology_group>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">-51</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746609">NO</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746610">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746611">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746616"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746621"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746626"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746627"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs/>
|
| 108 |
+
<rad:radiations/>
|
| 109 |
+
<lgg:follow_ups>
|
| 110 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 111 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A6CZ-F60216</clin_shared:bcr_followup_barcode>
|
| 112 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">6C5CF2CB-E23F-4BB2-AF28-E07457CC2F43</clin_shared:bcr_followup_uuid>
|
| 113 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628372">NO</clin_shared:lost_follow_up>
|
| 114 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628376">Alive</clin_shared:vital_status>
|
| 115 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628375">Stable Disease</clin_shared:primary_therapy_outcome_success>
|
| 116 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">279</clin_shared:days_to_last_followup>
|
| 117 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 118 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628386">NO</nte:new_tumor_event_after_initial_treatment>
|
| 119 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 120 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628391">NO</nte:additional_surgery_locoregional_procedure>
|
| 121 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 122 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628385">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 123 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 124 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628402">NO</nte:additional_pharmaceutical_therapy>
|
| 126 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628401">NO</nte:additional_radiation_therapy>
|
| 127 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">3</clin_shared:day_of_form_completion>
|
| 128 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 129 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 130 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628371">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 131 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 132 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 133 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628403">Stable Disease</clin_shared:followup_treatment_success>
|
| 135 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628374">NO</clin_shared:postoperative_rx_tx>
|
| 136 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628373">NO</clin_shared:radiation_therapy>
|
| 137 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 138 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3628396"/>
|
| 139 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 140 |
+
</follow_up_v1.0:follow_up>
|
| 141 |
+
</lgg:follow_ups>
|
| 142 |
+
</lgg:patient>
|
| 143 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/186eaec9-46f1-43ab-b7eb-afca51fcfbf9/nationwidechildrens.org_clinical.TCGA-S9-A6U0.xml
ADDED
|
@@ -0,0 +1,341 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">EF3D9A66-59F7-4752-A62D-663EA04E96FF</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">329.54.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059405">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059406">Astrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059420">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059413">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059447">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-16890</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">498</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059418">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">S9</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A6U0</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">A343FBE3-147A-4656-9E90-5408298CA12C</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059421">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9401/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059411">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059412">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">46</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059424">2012</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059425">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059456">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">31</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059419">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059502">Preoperative</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059507">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059409">Supratentorial, Temporal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059407">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059410">Cerebral Cortex</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059426">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059408">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059427">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059428">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059429">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059430">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059431">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059432">Seizures</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059433">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059434">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059435">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059436">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059437">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059438"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059439">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059440"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059441"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059442">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059443"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059444"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059445">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059446">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3059493"/>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3059494"/>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059495">YES</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059496">IHC</lgg:ldh1_mutation_test_method>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059497">NO</lgg:ldh1_mutation_found>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3059498"/>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059499"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059500">100</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059501">0</clin_shared:eastern_cancer_oncology_group>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">-18</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059508">YES</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059509">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3059510">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059515"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059520"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059559"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3059560"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295079">NO</rx:tx_on_clinical_trial>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0-D54135</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">E8308CBE-67F1-4074-B091-5B632DC7B1E5</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">30</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">64</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295082">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295080">Temozolomide</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3295081"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295087">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295092">Stable Disease</clin_shared:measure_of_response>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">17</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
<rx:drug>
|
| 138 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295096">NO</rx:tx_on_clinical_trial>
|
| 139 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 140 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0-D54136</rx:bcr_drug_barcode>
|
| 141 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">DB7B276C-FD50-475A-B68F-9974D22DFA38</rx:bcr_drug_uuid>
|
| 142 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 143 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 144 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 145 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 146 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 147 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">96</rx:days_to_drug_therapy_start>
|
| 148 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">264</rx:days_to_drug_therapy_end>
|
| 149 |
+
<rx:therapy_types>
|
| 150 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295099">Chemotherapy</rx:therapy_type>
|
| 151 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 152 |
+
</rx:therapy_types>
|
| 153 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295097">Temozolomide</rx:drug_name>
|
| 154 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3295098"/>
|
| 155 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 156 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 157 |
+
<rx:route_of_administrations>
|
| 158 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 159 |
+
</rx:route_of_administrations>
|
| 160 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295104">NO</rx:therapy_ongoing>
|
| 161 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295109">Stable Disease</clin_shared:measure_of_response>
|
| 162 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">17</clin_shared:day_of_form_completion>
|
| 163 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 164 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 165 |
+
</rx:drug>
|
| 166 |
+
<rx:drug>
|
| 167 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874502">NO</rx:tx_on_clinical_trial>
|
| 168 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 169 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0-D65506</rx:bcr_drug_barcode>
|
| 170 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">61FB2564-39E2-4F0F-B0B7-BE0E4D4F4ACD</rx:bcr_drug_uuid>
|
| 171 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 172 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 173 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 174 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 176 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">698</rx:days_to_drug_therapy_start>
|
| 177 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 178 |
+
<rx:therapy_types>
|
| 179 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874505">Targeted Molecular therapy</rx:therapy_type>
|
| 180 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 181 |
+
</rx:therapy_types>
|
| 182 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874503">Bevacizumab</rx:drug_name>
|
| 183 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3874504"/>
|
| 184 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 185 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 186 |
+
<rx:route_of_administrations>
|
| 187 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 188 |
+
</rx:route_of_administrations>
|
| 189 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874510">YES</rx:therapy_ongoing>
|
| 190 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3874515" xsi:nil="true"/>
|
| 191 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">24</clin_shared:day_of_form_completion>
|
| 192 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9</clin_shared:month_of_form_completion>
|
| 193 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 194 |
+
</rx:drug>
|
| 195 |
+
<rx:drug>
|
| 196 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074376">NO</rx:tx_on_clinical_trial>
|
| 197 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 198 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0-D70003</rx:bcr_drug_barcode>
|
| 199 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">75759921-173C-42B8-9F23-1ED2D3FA32FC</rx:bcr_drug_uuid>
|
| 200 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 201 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 202 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 203 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 204 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 205 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">603</rx:days_to_drug_therapy_start>
|
| 206 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 207 |
+
<rx:therapy_types>
|
| 208 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074379">Chemotherapy</rx:therapy_type>
|
| 209 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 210 |
+
</rx:therapy_types>
|
| 211 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074377">Carmustine</rx:drug_name>
|
| 212 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4074378"/>
|
| 213 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 214 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 215 |
+
<rx:route_of_administrations>
|
| 216 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 217 |
+
</rx:route_of_administrations>
|
| 218 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074384">NO</rx:therapy_ongoing>
|
| 219 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074389">Clinical Progressive Disease</clin_shared:measure_of_response>
|
| 220 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 221 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">1</clin_shared:month_of_form_completion>
|
| 222 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 223 |
+
</rx:drug>
|
| 224 |
+
<rx:drug>
|
| 225 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074409">NO</rx:tx_on_clinical_trial>
|
| 226 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 227 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0-D70005</rx:bcr_drug_barcode>
|
| 228 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">DE7BF179-1B4B-4870-AFA3-F954B842FD71</rx:bcr_drug_uuid>
|
| 229 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 230 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 231 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 232 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 233 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 234 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">603</rx:days_to_drug_therapy_start>
|
| 235 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000"/>
|
| 236 |
+
<rx:therapy_types>
|
| 237 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074412">Chemotherapy</rx:therapy_type>
|
| 238 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 239 |
+
</rx:therapy_types>
|
| 240 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074410">Teniposide</rx:drug_name>
|
| 241 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4074411"/>
|
| 242 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 243 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 244 |
+
<rx:route_of_administrations>
|
| 245 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 246 |
+
</rx:route_of_administrations>
|
| 247 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074417">NO</rx:therapy_ongoing>
|
| 248 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4074422">Clinical Progressive Disease</clin_shared:measure_of_response>
|
| 249 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 250 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">1</clin_shared:month_of_form_completion>
|
| 251 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 252 |
+
</rx:drug>
|
| 253 |
+
</rx:drugs>
|
| 254 |
+
<rad:radiations>
|
| 255 |
+
<rad:radiation>
|
| 256 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0-R54134</rad:bcr_radiation_barcode>
|
| 257 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">C2C4D8EA-77C5-4AC0-974D-EF7ACDD5BD1F</rad:bcr_radiation_uuid>
|
| 258 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">30</rad:days_to_radiation_therapy_start>
|
| 259 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">64</rad:days_to_radiation_therapy_end>
|
| 260 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295061">External</rad:radiation_type>
|
| 261 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 262 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295063">60</rad:radiation_dosage>
|
| 263 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295064">Gy</rad:units>
|
| 264 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295065">30</rad:numfractions>
|
| 265 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295062">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 266 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 267 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 268 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295070">NO</rad:radiation_treatment_ongoing>
|
| 269 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 270 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3295075">Stable Disease</clin_shared:measure_of_response>
|
| 271 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">17</clin_shared:day_of_form_completion>
|
| 272 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 273 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 274 |
+
</rad:radiation>
|
| 275 |
+
</rad:radiations>
|
| 276 |
+
<lgg:follow_ups>
|
| 277 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 278 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0-F65505</clin_shared:bcr_followup_barcode>
|
| 279 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">E6AAFF5B-8B77-45E0-B9DA-B6AE02E6C64E</clin_shared:bcr_followup_uuid>
|
| 280 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874406">NO</clin_shared:lost_follow_up>
|
| 281 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874410">Alive</clin_shared:vital_status>
|
| 282 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874409">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 283 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">698</clin_shared:days_to_last_followup>
|
| 284 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 285 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874420">YES</nte:new_tumor_event_after_initial_treatment>
|
| 286 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000">692</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 287 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3874425"/>
|
| 288 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 289 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874419">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 290 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 291 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 292 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874436">YES</nte:additional_pharmaceutical_therapy>
|
| 293 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874435">NO</nte:additional_radiation_therapy>
|
| 294 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">24</clin_shared:day_of_form_completion>
|
| 295 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9</clin_shared:month_of_form_completion>
|
| 296 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 297 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874405">Additional New Tumor Event</clin_shared:followup_case_report_form_submission_reason>
|
| 298 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 299 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 300 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 301 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874437">Progressive Disease</clin_shared:followup_treatment_success>
|
| 302 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874408">YES</clin_shared:postoperative_rx_tx>
|
| 303 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3874407">YES</clin_shared:radiation_therapy>
|
| 304 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 305 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3874430"/>
|
| 306 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 307 |
+
</follow_up_v1.0:follow_up>
|
| 308 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="2">
|
| 309 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6U0-F72340</clin_shared:bcr_followup_barcode>
|
| 310 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">311F9CE3-EB25-4E54-A3B3-081A1852C1EE</clin_shared:bcr_followup_uuid>
|
| 311 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159613">NO</clin_shared:lost_follow_up>
|
| 312 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159617">Dead</clin_shared:vital_status>
|
| 313 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159616">Partial Remission/Response</clin_shared:primary_therapy_outcome_success>
|
| 314 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Not Available" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000"/>
|
| 315 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Completed" preferred_name="death_days_to" display_order="54" cde_ver="1.000">742</clin_shared:days_to_death>
|
| 316 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159627">NO</nte:new_tumor_event_after_initial_treatment>
|
| 317 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 318 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4159632"/>
|
| 319 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 320 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159626">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 321 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 322 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 323 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4159643"/>
|
| 324 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4159642"/>
|
| 325 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">27</clin_shared:day_of_form_completion>
|
| 326 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">5</clin_shared:month_of_form_completion>
|
| 327 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2015</clin_shared:year_of_form_completion>
|
| 328 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159612">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 329 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 330 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 331 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 332 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159644">Progressive Disease</clin_shared:followup_treatment_success>
|
| 333 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159615">YES</clin_shared:postoperative_rx_tx>
|
| 334 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="4159614">YES</clin_shared:radiation_therapy>
|
| 335 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 336 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="4159637"/>
|
| 337 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 338 |
+
</follow_up_v1.0:follow_up>
|
| 339 |
+
</lgg:follow_ups>
|
| 340 |
+
</lgg:patient>
|
| 341 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/18dbac67-e2b7-42f8-9317-b070b710303b/nationwidechildrens.org_clinical.TCGA-QH-A6CV.xml
ADDED
|
@@ -0,0 +1,184 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">289EE22B-B96E-431C-BA9C-3A5BEF6605F4</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">319.55.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746186">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746187">Oligoastrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746201">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746194">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746228">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-18955</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">90</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746199">ASIAN</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A6CV</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">QH</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A6CV</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">29E95C77-F55B-42E1-B81E-EAB4BB3CF803</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746202">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9382/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746192">YES</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746193">NO</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">51</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746205">2013</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746206">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746237">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">8</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746200">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746247">Preoperative</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746252">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746190">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746188">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746191">White Matter</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746207">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746189">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746208">YES</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746209">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746210">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746211">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746212">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746213">Headaches</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746214">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746215">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746216">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746217">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746218">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746219"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746220">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746221"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746222"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746223">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746224"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746225"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746226">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746227">YES</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746238">NO</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746239">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746240">YES</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746241">Sequence Analysis</lgg:ldh1_mutation_test_method>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746242">YES</lgg:ldh1_mutation_found>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2746243"/>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746244"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746245">90</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746246">1</clin_shared:eastern_cancer_oncology_group>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">-42</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746253">NO</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2746254"/>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2746255">NO</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746260"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746265"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746270"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="2746271"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs/>
|
| 108 |
+
<rad:radiations>
|
| 109 |
+
<rad:radiation>
|
| 110 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A6CV-R46346</rad:bcr_radiation_barcode>
|
| 111 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">CEE9F6B3-471E-4853-B540-D2AD08C29729</rad:bcr_radiation_uuid>
|
| 112 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">50</rad:days_to_radiation_therapy_start>
|
| 113 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">90</rad:days_to_radiation_therapy_end>
|
| 114 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2765318">External</rad:radiation_type>
|
| 115 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 116 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2765320">54</rad:radiation_dosage>
|
| 117 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2765321">Gy</rad:units>
|
| 118 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2765322">27</rad:numfractions>
|
| 119 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2765319">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 120 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 121 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 122 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="2765327">NO</rad:radiation_treatment_ongoing>
|
| 123 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 124 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="2765332"/>
|
| 125 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9</clin_shared:day_of_form_completion>
|
| 126 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">12</clin_shared:month_of_form_completion>
|
| 127 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 128 |
+
</rad:radiation>
|
| 129 |
+
<rad:radiation>
|
| 130 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A6CV-R60217</rad:bcr_radiation_barcode>
|
| 131 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">E3F26EC2-720C-42DB-8776-E0B8D5888C04</rad:bcr_radiation_uuid>
|
| 132 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">348</rad:days_to_radiation_therapy_start>
|
| 133 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">351</rad:days_to_radiation_therapy_end>
|
| 134 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628407">External</rad:radiation_type>
|
| 135 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 136 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628409">24</rad:radiation_dosage>
|
| 137 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628410">Gy</rad:units>
|
| 138 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628411">3</rad:numfractions>
|
| 139 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628408">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 140 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 141 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 142 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628416">NO</rad:radiation_treatment_ongoing>
|
| 143 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 144 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628421">Stable Disease</clin_shared:measure_of_response>
|
| 145 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
|
| 146 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 147 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 148 |
+
</rad:radiation>
|
| 149 |
+
</rad:radiations>
|
| 150 |
+
<lgg:follow_ups>
|
| 151 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 152 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-QH-A6CV-F60218</clin_shared:bcr_followup_barcode>
|
| 153 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">70A70972-137D-40D1-89E8-AACCCB9AD568</clin_shared:bcr_followup_uuid>
|
| 154 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628426">NO</clin_shared:lost_follow_up>
|
| 155 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628430">Alive</clin_shared:vital_status>
|
| 156 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628429">Stable Disease</clin_shared:primary_therapy_outcome_success>
|
| 157 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">442</clin_shared:days_to_last_followup>
|
| 158 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 159 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628440">NO</nte:new_tumor_event_after_initial_treatment>
|
| 160 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 161 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628445">NO</nte:additional_surgery_locoregional_procedure>
|
| 162 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 163 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628439">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 164 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 165 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 166 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628456">NO</nte:additional_pharmaceutical_therapy>
|
| 167 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628455">NO</nte:additional_radiation_therapy>
|
| 168 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:day_of_form_completion>
|
| 169 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">6</clin_shared:month_of_form_completion>
|
| 170 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2014</clin_shared:year_of_form_completion>
|
| 171 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628425">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 172 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 173 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 174 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628457">Stable Disease</clin_shared:followup_treatment_success>
|
| 176 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628428">NO</clin_shared:postoperative_rx_tx>
|
| 177 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3628427">YES</clin_shared:radiation_therapy>
|
| 178 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 179 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3628450"/>
|
| 180 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 181 |
+
</follow_up_v1.0:follow_up>
|
| 182 |
+
</lgg:follow_ups>
|
| 183 |
+
</lgg:patient>
|
| 184 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/18eba95f-6cba-4125-a771-8e5d6107bb3d/nationwidechildrens.org_clinical.TCGA-S9-A6TS.xml
ADDED
|
@@ -0,0 +1,252 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">E1E2B41D-7E8D-43C1-B283-9FA6ED0DC291</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">347.51.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024180">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024181">Astrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024195">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024188">FEMALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024222">Dead</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-17857</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Completed" preferred_name="death_days_to" display_order="54" cde_ver="1.000">1891</clin_shared:days_to_death>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Not Available" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000"/>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024193">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6TS</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">S9</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A6TS</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">41E4DC71-7767-44C2-9D38-110DCD37B451</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024196">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9401/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024186">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024187">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">48</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024199">2006</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024200">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024231">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">30</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024194">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024241">Preoperative</clin_shared:performance_status_scale_timing>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024246">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024184">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024182">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024185">Cerebral Cortex</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024201">NO</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024183">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024202">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024203">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024204">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024205">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024206">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024207"/>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024208"/>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024209">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024210">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024211">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024212">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024213"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024214">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024215"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024216"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024217">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024218"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024219"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024220">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024221">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3024232"/>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3024233"/>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024234">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024235"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024236"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024237">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024238"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024239">100</clin_shared:karnofsky_performance_score>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024240">0</clin_shared:eastern_cancer_oncology_group>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Completed" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000">-10</clin_shared:days_to_performance_status_assessment>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024247">NO</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024248">Progressive Disease</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024249">YES</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000">1324</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024254">YES</nte:additional_surgery_locoregional_procedure>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000">1324</nte:days_to_additional_surgery_locoregional_procedure>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3024259"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024264">NO</nte:additional_radiation_therapy>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3024265">YES</nte:additional_pharmaceutical_therapy>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136014">NO</rx:tx_on_clinical_trial>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6TS-D51943</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">7263A8F3-DF15-43AC-AFFB-AFC300FD85C3</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">1614</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">1697</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136017">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136015">Carmustine</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3136016"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136022">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136027">Clinical Progressive Disease</clin_shared:measure_of_response>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
<rx:drug>
|
| 138 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135997">NO</rx:tx_on_clinical_trial>
|
| 139 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 140 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6TS-D51942</rx:bcr_drug_barcode>
|
| 141 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">58259028-B8FE-40C9-81C8-A5710FB35B17</rx:bcr_drug_uuid>
|
| 142 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 143 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 144 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 145 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 146 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 147 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">1352</rx:days_to_drug_therapy_start>
|
| 148 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">1603</rx:days_to_drug_therapy_end>
|
| 149 |
+
<rx:therapy_types>
|
| 150 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136000">Chemotherapy</rx:therapy_type>
|
| 151 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 152 |
+
</rx:therapy_types>
|
| 153 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135998">Temozolamide</rx:drug_name>
|
| 154 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3135999"/>
|
| 155 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 156 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 157 |
+
<rx:route_of_administrations>
|
| 158 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 159 |
+
</rx:route_of_administrations>
|
| 160 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136005">NO</rx:therapy_ongoing>
|
| 161 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136010">Clinical Progressive Disease</clin_shared:measure_of_response>
|
| 162 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 163 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
|
| 164 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 165 |
+
</rx:drug>
|
| 166 |
+
<rx:drug>
|
| 167 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136031">NO</rx:tx_on_clinical_trial>
|
| 168 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 169 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6TS-D51944</rx:bcr_drug_barcode>
|
| 170 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">2130E3E9-86B7-4792-ABF1-36699EE70C58</rx:bcr_drug_uuid>
|
| 171 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 172 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 173 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 174 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 176 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">1704</rx:days_to_drug_therapy_start>
|
| 177 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">1859</rx:days_to_drug_therapy_end>
|
| 178 |
+
<rx:therapy_types>
|
| 179 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136034">Targeted Molecular therapy</rx:therapy_type>
|
| 180 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 181 |
+
</rx:therapy_types>
|
| 182 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136032">Bevacizumab</rx:drug_name>
|
| 183 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3136033"/>
|
| 184 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 185 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 186 |
+
<rx:route_of_administrations>
|
| 187 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 188 |
+
</rx:route_of_administrations>
|
| 189 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136039">NO</rx:therapy_ongoing>
|
| 190 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136044">Clinical Progressive Disease</clin_shared:measure_of_response>
|
| 191 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 192 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
|
| 193 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 194 |
+
</rx:drug>
|
| 195 |
+
</rx:drugs>
|
| 196 |
+
<rad:radiations>
|
| 197 |
+
<rad:radiation>
|
| 198 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6TS-R51941</rad:bcr_radiation_barcode>
|
| 199 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">C2573AC2-6094-484C-8447-D7001862CBFC</rad:bcr_radiation_uuid>
|
| 200 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">0</rad:days_to_radiation_therapy_start>
|
| 201 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">78</rad:days_to_radiation_therapy_end>
|
| 202 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135979">External</rad:radiation_type>
|
| 203 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 204 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135981">59.4</rad:radiation_dosage>
|
| 205 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135982">Gy</rad:units>
|
| 206 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135983">33</rad:numfractions>
|
| 207 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135980">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 208 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 209 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 210 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135988">NO</rad:radiation_treatment_ongoing>
|
| 211 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 212 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3135993">Stable Disease</clin_shared:measure_of_response>
|
| 213 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 214 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
|
| 215 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 216 |
+
</rad:radiation>
|
| 217 |
+
</rad:radiations>
|
| 218 |
+
<lgg:follow_ups>
|
| 219 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 220 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-S9-A6TS-F51945</clin_shared:bcr_followup_barcode>
|
| 221 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">74B6FEC2-31FE-4373-93A8-2FA1CD37B9BE</clin_shared:bcr_followup_uuid>
|
| 222 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136069">NO</clin_shared:lost_follow_up>
|
| 223 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136073">Dead</clin_shared:vital_status>
|
| 224 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136072">Progressive Disease</clin_shared:primary_therapy_outcome_success>
|
| 225 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Not Available" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000"/>
|
| 226 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Completed" preferred_name="death_days_to" display_order="54" cde_ver="1.000">1891</clin_shared:days_to_death>
|
| 227 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136083">YES</nte:new_tumor_event_after_initial_treatment>
|
| 228 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000">1324</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 229 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136088">YES</nte:additional_surgery_locoregional_procedure>
|
| 230 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000">1324</nte:days_to_additional_surgery_locoregional_procedure>
|
| 231 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136082">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 232 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 233 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 234 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136099">YES</nte:additional_pharmaceutical_therapy>
|
| 235 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136098">NO</nte:additional_radiation_therapy>
|
| 236 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">26</clin_shared:day_of_form_completion>
|
| 237 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">11</clin_shared:month_of_form_completion>
|
| 238 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 239 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136068">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 240 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 241 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 242 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 243 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136100">Progressive Disease</clin_shared:followup_treatment_success>
|
| 244 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136071">NO</clin_shared:postoperative_rx_tx>
|
| 245 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3136070">YES</clin_shared:radiation_therapy>
|
| 246 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 247 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3136093"/>
|
| 248 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 249 |
+
</follow_up_v1.0:follow_up>
|
| 250 |
+
</lgg:follow_ups>
|
| 251 |
+
</lgg:patient>
|
| 252 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/190d2fa6-a8ee-49f7-9bab-4babaf3da73d/nationwidechildrens.org_omf.TCGA-DU-A76O.xml
ADDED
|
@@ -0,0 +1,70 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<omf:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/omf/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/omf/2.7/TCGA_BCR.Other_Malignancies.xsd" schemaVersion="2.7" xmlns:omf="http://tcga.nci/bcr/xml/clinical/omf/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:omf_v4.0="http://tcga.nci/bcr/xml/clinical/omf/2.7/4.0" xmlns:omf_shared="http://tcga.nci/bcr/xml/clinical/shared/omf/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:shared_stage="http://tcga.nci/bcr/xml/clinical/shared/stage/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">BCF1629C-5617-4E2A-B57D-35FF75F34051</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">329.54.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<omf:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">DU</shared:tissue_source_site>
|
| 21 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A76O</shared:patient_id>
|
| 22 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DU-A76O</shared:bcr_patient_barcode>
|
| 23 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">C56FA247-AD97-4DCE-A2D3-9BDFC5DC7B1B</shared:bcr_patient_uuid>
|
| 24 |
+
<omf:omfs>
|
| 25 |
+
<omf_v4.0:omf>
|
| 26 |
+
<omf_shared:bcr_omf_barcode xsd_ver="2.6" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DU-A76O-O50236</omf_shared:bcr_omf_barcode>
|
| 27 |
+
<omf_shared:bcr_omf_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.6" owner="TSS" procurement_status="Completed" restricted="false">F1D1E751-084C-4E18-921D-5812904C88C7</omf_shared:bcr_omf_uuid>
|
| 28 |
+
<omf_shared:malignancy_type preferred_name="malignancy_type" display_order="4" cde="3182890" cde_ver="1.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022402">Prior Malignancy</omf_shared:malignancy_type>
|
| 29 |
+
<omf_shared:other_malignancy_anatomic_site preferred_name="" display_order="9999" cde="4122351" cde_ver="" xsd_ver="2.6" tier="" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022403">Leg</omf_shared:other_malignancy_anatomic_site>
|
| 30 |
+
<omf_shared:other_malignancy_anatomic_site_text preferred_name="" display_order="9999" cde="4122371" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false" source_system_identifier="3022404" xsi:nil="true"/>
|
| 31 |
+
<omf_shared:other_malignancy_laterality preferred_name="" display_order="9999" cde="4122391" cde_ver="" xsd_ver="2.6" tier="" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022405">Left</omf_shared:other_malignancy_laterality>
|
| 32 |
+
<omf_shared:other_malignancy_histological_type preferred_name="" display_order="9999" cde="4122411" cde_ver="" xsd_ver="2.6" tier="" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022406">Other, specify</omf_shared:other_malignancy_histological_type>
|
| 33 |
+
<omf_shared:other_malignancy_histological_type_text preferred_name="" display_order="9999" cde="4122431" cde_ver="" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022407">enchondrosarcoma</omf_shared:other_malignancy_histological_type_text>
|
| 34 |
+
<omf_shared:days_to_other_malignancy_dx precision="day" xsd_ver="2.6" tier="2" cde="3462301" owner="TSS" procurement_status="Completed" preferred_name="other_malignancy_dx_days_to" display_order="13" cde_ver="1.000">-6573</omf_shared:days_to_other_malignancy_dx>
|
| 35 |
+
<omf_shared:surgery>
|
| 36 |
+
<shared:surgery_indicator preferred_name="surgery_indicator" display_order="14" cde="3186538" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022412">YES</shared:surgery_indicator>
|
| 37 |
+
<omf_shared:surgery_type preferred_name="other_malignancy_surgery_type" display_order="15" cde="3462300" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022413">left above knee amputation</omf_shared:surgery_type>
|
| 38 |
+
<omf_shared:days_to_surgical_resection precision="day" xsd_ver="2.6" tier="2" cde="3462302" owner="TSS" procurement_status="Completed" preferred_name="other_malignancy_surgery_days_to" display_order="19" cde_ver="1.000">-6573</omf_shared:days_to_surgical_resection>
|
| 39 |
+
</omf_shared:surgery>
|
| 40 |
+
<omf_shared:drug_tx>
|
| 41 |
+
<shared:drug_tx_indicator preferred_name="pharmaceutical_therapy_indicator" display_order="20" cde="3178327" cde_ver="1.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022418">NO</shared:drug_tx_indicator>
|
| 42 |
+
<omf_shared:drug_tx_extent preferred_name="pharmaceutical_therapy_extent" display_order="21" cde="3178365" cde_ver="1.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3022419"/>
|
| 43 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Not Available" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000"/>
|
| 44 |
+
<omf_shared:administered_drug>
|
| 45 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3022420"/>
|
| 46 |
+
</omf_shared:administered_drug>
|
| 47 |
+
</omf_shared:drug_tx>
|
| 48 |
+
<omf_shared:radiation_tx>
|
| 49 |
+
<omf_shared:radiation_tx_indicator preferred_name="radiation_therapy_indicator" display_order="27" cde="3178328" cde_ver="1.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3022425">NO</omf_shared:radiation_tx_indicator>
|
| 50 |
+
<omf_shared:radiation_tx_extent preferred_name="radiation_therapy_extent" display_order="28" cde="3178353" cde_ver="1.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3022426"/>
|
| 51 |
+
<omf_shared:rad_tx_to_site_of_primary_tumor preferred_name="history_rt_tx_to_site_of_tcga_tumor" display_order="29" cde="2865132" cde_ver="1.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3022427"/>
|
| 52 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Not Available" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000"/>
|
| 53 |
+
</omf_shared:radiation_tx>
|
| 54 |
+
<omf_shared:omf_staging>
|
| 55 |
+
<shared_stage:system_version preferred_name="ajcc_staging_edition" display_order="36" cde="2722309" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 56 |
+
<shared_stage:clinical_stage preferred_name="figo_clinical_tumor_stage" display_order="9999" cde="3225684" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 57 |
+
<shared_stage:pathologic_stage preferred_name="ajcc_pathologic_tumor_stage" display_order="40" cde="3203222" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3022438"/>
|
| 58 |
+
<shared_stage:pathologic_categories>
|
| 59 |
+
<shared_stage:pathologic_T preferred_name="ajcc_tumor_pathologic_pt" display_order="37" cde="3045435" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3022435"/>
|
| 60 |
+
<shared_stage:pathologic_N preferred_name="ajcc_nodes_pathologic_pn" display_order="38" cde="3203106" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3022436"/>
|
| 61 |
+
<shared_stage:pathologic_M preferred_name="ajcc_metastasis_pathologic_pm" display_order="39" cde="3045439" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3022437"/>
|
| 62 |
+
</shared_stage:pathologic_categories>
|
| 63 |
+
</omf_shared:omf_staging>
|
| 64 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">18</clin_shared:day_of_form_completion>
|
| 65 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 66 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 67 |
+
</omf_v4.0:omf>
|
| 68 |
+
</omf:omfs>
|
| 69 |
+
</omf:patient>
|
| 70 |
+
</omf:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/191c5c43-b7f4-4b16-9710-024180600d88/TCGA-P5-A735.7950CF04-F8C0-4855-A108-BB15B1B65B0D.PDF
ADDED
|
Binary file (58.3 kB). View file
|
|
|
CT/lung2/data/raw/gdc/clinical/1922985c-8b0f-4b69-bf0c-109823e200b8/nationwidechildrens.org_clinical.TCGA-HT-8106.xml
ADDED
|
@@ -0,0 +1,143 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7" xmlns:follow_up_v1.0="http://tcga.nci/bcr/xml/clinical/lgg/followup/2.7/1.0">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">EDC71B4A-7AEA-4EFA-8EB6-30A71D874976</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">245.75.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899222">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899223">Astrocytoma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899234">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899228">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899261">Alive</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-19555</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">3</clin_shared:days_to_last_followup>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899232">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-8106</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">HT</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">8106</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">bae316e3-1fa4-4fa7-8ad6-a458857a85d4</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899238">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9401/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899282">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899283">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">53</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899237">2010</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899239">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899268"/>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899220">3</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899219">5</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899221">2012</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899233">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899278"/>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899226">Supratentorial, Frontal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899224">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899227">Not listed in Medical Record</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899240">YES</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899225">Midline</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899241">NO</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899242">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899243">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899244">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899245">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899246">Seizures</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899247">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899248">NO</lgg:asthma_history>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899249">NO</lgg:eczema_history>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899250">NO</lgg:hay_fever_history>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899251">NO</lgg:mold_or_dust_allergy_history>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899252"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899253">NO</lgg:food_allergy_history>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899254"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899255"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899256">NO</lgg:animal_insect_allergy_history>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899257"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899258"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899259">NO</lgg:preoperative_corticosteroids>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899260">NO</lgg:preoperative_antiseizure_meds>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899269">NO</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899270">NO</lgg:family_history_of_primary_brain_tumor>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899271">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899272"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899273"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1899274">NO</lgg:inherited_genetic_syndrome_found>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899275"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899276"/>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1899277"/>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs/>
|
| 108 |
+
<rad:radiations/>
|
| 109 |
+
<lgg:follow_ups>
|
| 110 |
+
<follow_up_v1.0:follow_up version="1.0" sequence="1">
|
| 111 |
+
<clin_shared:bcr_followup_barcode preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">TCGA-HT-8106-F32632</clin_shared:bcr_followup_barcode>
|
| 112 |
+
<clin_shared:bcr_followup_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.5" owner="TSS" procurement_status="Completed" restricted="false">cfde7285-8d0e-4079-9649-78ae297d9ef3</clin_shared:bcr_followup_uuid>
|
| 113 |
+
<clin_shared:lost_follow_up preferred_name="followup_lost_to" display_order="5" cde="61333" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958284">Alive</clin_shared:vital_status>
|
| 115 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958283">Stable Disease</clin_shared:primary_therapy_outcome_success>
|
| 116 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Completed" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000">3</clin_shared:days_to_last_followup>
|
| 117 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Not Applicable" preferred_name="death_days_to" display_order="54" cde_ver="1.000"/>
|
| 118 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958292">NO</nte:new_tumor_event_after_initial_treatment>
|
| 119 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000"/>
|
| 120 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1958296"/>
|
| 121 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000"/>
|
| 122 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958291">TUMOR FREE</clin_shared:person_neoplasm_cancer_status>
|
| 123 |
+
<nte:new_neoplasm_event_type preferred_name="new_tumor_event_type" display_order="9999" cde="3119721" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 124 |
+
<clin_shared:patient_death_reason preferred_name="cause_of_death" display_order="9999" cde="2554674" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 125 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1958311"/>
|
| 126 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1958310"/>
|
| 127 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958238">4</clin_shared:day_of_form_completion>
|
| 128 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958237">6</clin_shared:month_of_form_completion>
|
| 129 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958239">2012</clin_shared:year_of_form_completion>
|
| 130 |
+
<clin_shared:followup_case_report_form_submission_reason preferred_name="followup_reason" display_order="4" cde="3233305" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958240">Scheduled Follow-up Submission</clin_shared:followup_case_report_form_submission_reason>
|
| 131 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1958316"/>
|
| 132 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1958317"/>
|
| 133 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1958318"/>
|
| 134 |
+
<clin_shared:followup_treatment_success preferred_name="treatment_outcome_at_tcga_followup" display_order="36" cde="3104050" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958312">Stable Disease</clin_shared:followup_treatment_success>
|
| 135 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958282">NO</clin_shared:postoperative_rx_tx>
|
| 136 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="1958281">NO</clin_shared:radiation_therapy>
|
| 137 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 138 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="1958300"/>
|
| 139 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 140 |
+
</follow_up_v1.0:follow_up>
|
| 141 |
+
</lgg:follow_ups>
|
| 142 |
+
</lgg:patient>
|
| 143 |
+
</lgg:tcga_bcr>
|
CT/lung2/data/raw/gdc/clinical/1984e470-74ee-4d4e-8b76-d97ab7f83308/nationwidechildrens.org_clinical.TCGA-DU-A76L.xml
ADDED
|
@@ -0,0 +1,249 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
<?xml version="1.0" encoding="UTF-8"?>
|
| 2 |
+
<lgg:tcga_bcr xsi:schemaLocation="http://tcga.nci/bcr/xml/clinical/lgg/2.7 https://raw.githubusercontent.com/nchbcr/xsd/2.7/tcga.nci/bcr/xml/clinical/lgg/2.7/TCGA_BCR.LGG_Clinical.xsd" schemaVersion="2.7" xmlns:lgg="http://tcga.nci/bcr/xml/clinical/lgg/2.7" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:admin="http://tcga.nci/bcr/xml/administration/2.7" xmlns:clin_shared="http://tcga.nci/bcr/xml/clinical/shared/2.7" xmlns:shared="http://tcga.nci/bcr/xml/shared/2.7" xmlns:lgg_nte="http://tcga.nci/bcr/xml/clinical/lgg/shared/new_tumor_event/2.7/1.0" xmlns:nte="http://tcga.nci/bcr/xml/clinical/shared/new_tumor_event/2.7" xmlns:rx="http://tcga.nci/bcr/xml/clinical/pharmaceutical/2.7" xmlns:rad="http://tcga.nci/bcr/xml/clinical/radiation/2.7">
|
| 3 |
+
<admin:admin>
|
| 4 |
+
<admin:bcr xsd_ver="1.17">Nationwide Children's Hospital</admin:bcr>
|
| 5 |
+
<admin:file_uuid xsd_ver="2.6">22488A71-37A1-43DB-B584-880CEB56EFE7</admin:file_uuid>
|
| 6 |
+
<admin:batch_number xsd_ver="1.17">329.54.0</admin:batch_number>
|
| 7 |
+
<admin:project_code xsd_ver="2.7">TCGA</admin:project_code>
|
| 8 |
+
<admin:disease_code xsd_ver="2.6">LGG</admin:disease_code>
|
| 9 |
+
<admin:day_of_dcc_upload xsd_ver="1.17">22</admin:day_of_dcc_upload>
|
| 10 |
+
<admin:month_of_dcc_upload xsd_ver="1.17">12</admin:month_of_dcc_upload>
|
| 11 |
+
<admin:year_of_dcc_upload xsd_ver="1.17">2016</admin:year_of_dcc_upload>
|
| 12 |
+
<admin:patient_withdrawal>
|
| 13 |
+
<admin:withdrawn>false</admin:withdrawn>
|
| 14 |
+
</admin:patient_withdrawal>
|
| 15 |
+
<admin:program xsi:nil="true" xsd_ver="2.7"/>
|
| 16 |
+
<admin:dbgap_registration_code xsi:nil="true" xsd_ver="2.7"/>
|
| 17 |
+
</admin:admin>
|
| 18 |
+
<lgg:patient>
|
| 19 |
+
<admin:additional_studies/>
|
| 20 |
+
<clin_shared:tumor_tissue_site preferred_name="submitted_tumor_site" display_order="9999" cde="3427536" cde_ver="2.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028310">Central nervous system</clin_shared:tumor_tissue_site>
|
| 21 |
+
<shared:histological_type preferred_name="histologic_diagnosis" display_order="5" cde="3081934" cde_ver="3.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028311">Oligodendroglioma</shared:histological_type>
|
| 22 |
+
<shared:other_dx preferred_name="history_other_malignancy" display_order="19" cde="3382736" cde_ver="2.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028325">No</shared:other_dx>
|
| 23 |
+
<shared:gender preferred_name="gender" display_order="12" cde="2200604" cde_ver="3.000" xsd_ver="1.8" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028318">MALE</shared:gender>
|
| 24 |
+
<clin_shared:vital_status preferred_name="vital_status" display_order="46" cde="5" cde_ver="5.000" xsd_ver="2.6" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028352">Dead</clin_shared:vital_status>
|
| 25 |
+
<clin_shared:days_to_birth precision="day" xsd_ver="1.12" tier="1" cde="3008233" owner="TSS" procurement_status="Completed" preferred_name="birth_days_to" display_order="16" cde_ver="1.000">-19823</clin_shared:days_to_birth>
|
| 26 |
+
<clin_shared:days_to_last_known_alive precision="day" xsd_ver="2.1" tier="2" cde="" owner="TSS" procurement_status="Not Available" preferred_name="" display_order="9999" cde_ver=""/>
|
| 27 |
+
<clin_shared:days_to_death precision="day" xsd_ver="1.12" tier="1" cde="3165475" owner="TSS" procurement_status="Completed" preferred_name="death_days_to" display_order="54" cde_ver="1.000">814</clin_shared:days_to_death>
|
| 28 |
+
<clin_shared:days_to_last_followup precision="day" xsd_ver="1.12" tier="1" cde="3008273" owner="TSS" procurement_status="Not Available" preferred_name="last_contact_days_to" display_order="50" cde_ver="1.000"/>
|
| 29 |
+
<clin_shared:race_list>
|
| 30 |
+
<clin_shared:race preferred_name="race" display_order="17" cde="2192199" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028323">WHITE</clin_shared:race>
|
| 31 |
+
</clin_shared:race_list>
|
| 32 |
+
<shared:bcr_patient_barcode preferred_name="" display_order="9999" cde="2003301" cde_ver="" xsd_ver="1.8" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DU-A76L</shared:bcr_patient_barcode>
|
| 33 |
+
<shared:tissue_source_site cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">DU</shared:tissue_source_site>
|
| 34 |
+
<shared:patient_id cde="" cde_ver="" xsd_ver="2.4" owner="TSS" procurement_status="Completed" restricted="false">A76L</shared:patient_id>
|
| 35 |
+
<shared:bcr_patient_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">395798C5-3136-4A30-8557-A67A3ABDECAF</shared:bcr_patient_uuid>
|
| 36 |
+
<shared:history_of_neoadjuvant_treatment preferred_name="history_neoadjuvant_treatment" display_order="20" cde="3382737" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028326">No</shared:history_of_neoadjuvant_treatment>
|
| 37 |
+
<clin_shared:informed_consent_verified preferred_name="patient_consent_status" display_order="14" cde="3288361" cde_ver="1.000" xsd_ver="2.4" tier="1" owner="TSS" procurement_status="Completed" restricted="false">YES</clin_shared:informed_consent_verified>
|
| 38 |
+
<clin_shared:icd_o_3_site preferred_name="" display_order="9999" cde="3226281" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_o_3_site>
|
| 39 |
+
<clin_shared:icd_o_3_histology preferred_name="" display_order="9999" cde="3226275" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">9451/3</clin_shared:icd_o_3_histology>
|
| 40 |
+
<clin_shared:icd_10 preferred_name="" display_order="9999" cde="3226287" cde_ver="" xsd_ver="2.4" tier="2" owner="TSS" procurement_status="Completed" restricted="false">C71.0</clin_shared:icd_10>
|
| 41 |
+
<clin_shared:tissue_prospective_collection_indicator preferred_name="prospective_collection" display_order="10" cde="3088492" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028316">NO</clin_shared:tissue_prospective_collection_indicator>
|
| 42 |
+
<clin_shared:tissue_retrospective_collection_indicator preferred_name="retrospective_collection" display_order="11" cde="3088528" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028317">YES</clin_shared:tissue_retrospective_collection_indicator>
|
| 43 |
+
<clin_shared:days_to_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="3131740" owner="TSS" procurement_status="Completed" preferred_name="initial_pathologic_dx_days_to" display_order="9999" cde_ver="1.000">0</clin_shared:days_to_initial_pathologic_diagnosis>
|
| 44 |
+
<clin_shared:age_at_initial_pathologic_diagnosis precision="day" xsd_ver="1.12" tier="1" cde="2006657" owner="TSS" procurement_status="Completed">54</clin_shared:age_at_initial_pathologic_diagnosis>
|
| 45 |
+
<clin_shared:year_of_initial_pathologic_diagnosis preferred_name="initial_pathologic_dx_year" display_order="23" cde="2896960" cde_ver="1.000" xsd_ver="1.12" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028329">2000</clin_shared:year_of_initial_pathologic_diagnosis>
|
| 46 |
+
<lgg:history_ionizing_rt_to_head preferred_name="history_ionizing_rt_to_head" display_order="24" cde="3120926" cde_ver="1.000" xsd_ver="2.6" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028330">NO</lgg:history_ionizing_rt_to_head>
|
| 47 |
+
<clin_shared:person_neoplasm_cancer_status preferred_name="tumor_status" display_order="55" cde="2759550" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028361">WITH TUMOR</clin_shared:person_neoplasm_cancer_status>
|
| 48 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">22</clin_shared:day_of_form_completion>
|
| 49 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 50 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 51 |
+
<clin_shared:ethnicity preferred_name="ethnicity" display_order="18" cde="2192217" cde_ver="2.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028324">NOT HISPANIC OR LATINO</clin_shared:ethnicity>
|
| 52 |
+
<clin_shared:performance_status_scale_timing preferred_name="performance_status_timing" display_order="65" cde="2792763" cde_ver="1.000" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028371"/>
|
| 53 |
+
<clin_shared:radiation_therapy preferred_name="radiation_treatment_adjuvant" display_order="70" cde="2005312" cde_ver="4.000" xsd_ver="1.9" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028376">YES</clin_shared:radiation_therapy>
|
| 54 |
+
<lgg:tumor_location preferred_name="tumor_site" display_order="8" cde="3139375" cde_ver="1.000" xsd_ver="2.3" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028314">Supratentorial, Temporal Lobe</lgg:tumor_location>
|
| 55 |
+
<shared:neoplasm_histologic_grade preferred_name="tumor_grade" display_order="6" cde="2785839" cde_ver="2.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028312">G3</shared:neoplasm_histologic_grade>
|
| 56 |
+
<lgg:supratentorial_localization preferred_name="supratentorial_localization" display_order="9" cde="3133891" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028315">Not listed in Medical Record</lgg:supratentorial_localization>
|
| 57 |
+
<lgg:seizure_history preferred_name="history_seizures" display_order="25" cde="3121333" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028331">NO</lgg:seizure_history>
|
| 58 |
+
<clin_shared:laterality preferred_name="laterality" display_order="7" cde="827" cde_ver="3.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028313">Right</clin_shared:laterality>
|
| 59 |
+
<lgg:headache_history preferred_name="history_headaches" display_order="26" cde="3121345" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028332">YES</lgg:headache_history>
|
| 60 |
+
<lgg:mental_status_changes preferred_name="symp_changes_mental_status" display_order="27" cde="3121352" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028333">NO</lgg:mental_status_changes>
|
| 61 |
+
<lgg:visual_changes preferred_name="symp_changes_visual" display_order="28" cde="3121359" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028334">NO</lgg:visual_changes>
|
| 62 |
+
<lgg:sensory_changes preferred_name="symp_changes_sensory" display_order="29" cde="3121365" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028335">NO</lgg:sensory_changes>
|
| 63 |
+
<lgg:motor_movement_changes preferred_name="symp_changes_motor_movement" display_order="30" cde="3120991" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028336">NO</lgg:motor_movement_changes>
|
| 64 |
+
<lgg:first_presenting_symptom preferred_name="related_symptom_first_present" display_order="31" cde="3133911" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028337">Headaches</lgg:first_presenting_symptom>
|
| 65 |
+
<lgg:first_presenting_symptom_longest_duration preferred_name="first_symptom_longest_duration" display_order="32" cde="3121001" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028338">0 - 30 Days</lgg:first_presenting_symptom_longest_duration>
|
| 66 |
+
<lgg:asthma_history preferred_name="history_asthma" display_order="33" cde="3133921" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028339"/>
|
| 67 |
+
<lgg:eczema_history preferred_name="history_eczema" display_order="34" cde="3133925" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028340"/>
|
| 68 |
+
<lgg:hay_fever_history preferred_name="histor_hay_fever" display_order="35" cde="3133930" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028341"/>
|
| 69 |
+
<lgg:mold_or_dust_allergy_history preferred_name="history_dust_mold_allergy" display_order="36" cde="3133934" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028342"/>
|
| 70 |
+
<lgg:first_diagnosis_age_asth_ecz_hay_fev_mold_dust preferred_name="asthma_eczema_allergy_first_dx" display_order="37" cde="3121273" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028343"/>
|
| 71 |
+
<lgg:food_allergy_history preferred_name="allergy_food_dx_indicator" display_order="38" cde="3121278" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028344"/>
|
| 72 |
+
<lgg:food_allergy_types preferred_name="allergy_food_dx_type" display_order="39" cde="3121280" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028345"/>
|
| 73 |
+
<lgg:first_diagnosis_age_of_food_allergy preferred_name="allergy_food_dx_age" display_order="40" cde="3121301" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028346"/>
|
| 74 |
+
<lgg:animal_insect_allergy_history preferred_name="allergy_animals_insects_dx_indicator" display_order="41" cde="3121314" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028347"/>
|
| 75 |
+
<lgg:animal_insect_allergy_types preferred_name="allergy_animals_insects_dx_type" display_order="42" cde="3121316" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028348"/>
|
| 76 |
+
<lgg:first_diagnosis_age_of_animal_insect_allergy preferred_name="allergy_animals_insects_dx_age" display_order="43" cde="3121318" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028349"/>
|
| 77 |
+
<lgg:preoperative_corticosteroids preferred_name="history_neoadjuvant_steroid_tx" display_order="44" cde="3121323" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028350"/>
|
| 78 |
+
<lgg:preoperative_antiseizure_meds preferred_name="history_neoadjuvant_medication" display_order="45" cde="3121328" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028351"/>
|
| 79 |
+
<lgg:family_history_of_cancer preferred_name="family_history_cancer_indicator" display_order="56" cde="2436860" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028362">YES</lgg:family_history_of_cancer>
|
| 80 |
+
<lgg:family_history_of_primary_brain_tumor preferred_name="family_history_brain_tumor" display_order="57" cde="3133957" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028363"/>
|
| 81 |
+
<lgg:ldh1_mutation_tested preferred_name="idh1_mutation_test_indicator" display_order="58" cde="3133962" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028364">NO</lgg:ldh1_mutation_tested>
|
| 82 |
+
<lgg:ldh1_mutation_test_method preferred_name="idh1_mutation_test_method" display_order="59" cde="3133963" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028365"/>
|
| 83 |
+
<lgg:ldh1_mutation_found preferred_name="idh1_mutation_found" display_order="60" cde="3133967" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028366"/>
|
| 84 |
+
<lgg:inherited_genetic_syndrome_found preferred_name="inherited_genetic_syndrome_indicator" display_order="61" cde="3133971" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Unknown" restricted="false" source_system_identifier="3028367"/>
|
| 85 |
+
<lgg:inherited_genetic_syndrome_result preferred_name="inherited_genetic_syndrome_specified" display_order="62" cde="3133974" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028368"/>
|
| 86 |
+
<clin_shared:karnofsky_performance_score preferred_name="karnofsky_score" display_order="63" cde="2003853" cde_ver="4.200" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Evaluated" restricted="false" source_system_identifier="3028369"/>
|
| 87 |
+
<clin_shared:eastern_cancer_oncology_group preferred_name="ecog_score" display_order="64" cde="88" cde_ver="5.100" xsd_ver="1.9" tier="2" owner="TSS" procurement_status="Not Evaluated" restricted="false" source_system_identifier="3028370"/>
|
| 88 |
+
<clin_shared:days_to_performance_status_assessment precision="day" xsd_ver="2.5" tier="2" cde="3479270" owner="TSS" procurement_status="Not Available" preferred_name="performance_status_days_to" display_order="69" cde_ver="1.000"/>
|
| 89 |
+
<clin_shared:postoperative_rx_tx preferred_name="pharmaceutical_tx_adjuvant" display_order="71" cde="3397567" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028377">YES</clin_shared:postoperative_rx_tx>
|
| 90 |
+
<clin_shared:primary_therapy_outcome_success preferred_name="treatment_outcome_first_course" display_order="72" cde="2786727" cde_ver="3.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028378">Progressive Disease</clin_shared:primary_therapy_outcome_success>
|
| 91 |
+
<lgg_nte:new_tumor_events>
|
| 92 |
+
<nte:new_tumor_event_after_initial_treatment preferred_name="new_tumor_event_dx_indicator" display_order="73" cde="3121376" cde_ver="1.000" xsd_ver="2.5" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028399">YES</nte:new_tumor_event_after_initial_treatment>
|
| 93 |
+
<lgg_nte:new_tumor_event>
|
| 94 |
+
<nte:days_to_new_tumor_event_after_initial_treatment precision="day" xsd_ver="2.2" tier="1" cde="3392464" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_dx_days_to" display_order="77" cde_ver="1.000">410</nte:days_to_new_tumor_event_after_initial_treatment>
|
| 95 |
+
<lgg_nte:locoregional_procedure>
|
| 96 |
+
<nte:additional_surgery_locoregional_procedure preferred_name="new_tumor_event_surgery" display_order="78" cde="3008755" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028404">YES</nte:additional_surgery_locoregional_procedure>
|
| 97 |
+
<nte:days_to_additional_surgery_locoregional_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408572" owner="TSS" procurement_status="Completed" preferred_name="new_tumor_event_surgery_days_to_loco" display_order="82" cde_ver="1.000">441</nte:days_to_additional_surgery_locoregional_procedure>
|
| 98 |
+
</lgg_nte:locoregional_procedure>
|
| 99 |
+
<lgg_nte:metastatic_procedure>
|
| 100 |
+
<nte:additional_surgery_metastatic_procedure preferred_name="new_tumor_event_surgery_met" display_order="83" cde="3008757" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028409">NO</nte:additional_surgery_metastatic_procedure>
|
| 101 |
+
<nte:days_to_additional_surgery_metastatic_procedure precision="day" xsd_ver="2.2" tier="2" cde="3408682" owner="TSS" procurement_status="Not Available" preferred_name="new_tumor_event_surgery_days_to_met" display_order="87" cde_ver="1.000"/>
|
| 102 |
+
</lgg_nte:metastatic_procedure>
|
| 103 |
+
<nte:additional_radiation_therapy preferred_name="new_tumor_event_radiation_tx" display_order="88" cde="3427615" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028414">NO</nte:additional_radiation_therapy>
|
| 104 |
+
<nte:additional_pharmaceutical_therapy preferred_name="new_tumor_event_pharmaceutical_tx" display_order="89" cde="3427616" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028415">YES</nte:additional_pharmaceutical_therapy>
|
| 105 |
+
</lgg_nte:new_tumor_event>
|
| 106 |
+
</lgg_nte:new_tumor_events>
|
| 107 |
+
<rx:drugs>
|
| 108 |
+
<rx:drug>
|
| 109 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028437">NO</rx:tx_on_clinical_trial>
|
| 110 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 111 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DU-A76L-D50323</rx:bcr_drug_barcode>
|
| 112 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">17E31019-21A1-48CA-8472-48CD1CEAD9B5</rx:bcr_drug_uuid>
|
| 113 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 114 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 115 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 116 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 117 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 118 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">16</rx:days_to_drug_therapy_start>
|
| 119 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">57</rx:days_to_drug_therapy_end>
|
| 120 |
+
<rx:therapy_types>
|
| 121 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028440">Chemotherapy</rx:therapy_type>
|
| 122 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 123 |
+
</rx:therapy_types>
|
| 124 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028438">Temozolomide</rx:drug_name>
|
| 125 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028439"/>
|
| 126 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 127 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 128 |
+
<rx:route_of_administrations>
|
| 129 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 130 |
+
</rx:route_of_administrations>
|
| 131 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028445">NO</rx:therapy_ongoing>
|
| 132 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028450">Stable Disease</clin_shared:measure_of_response>
|
| 133 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">22</clin_shared:day_of_form_completion>
|
| 134 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 135 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 136 |
+
</rx:drug>
|
| 137 |
+
<rx:drug>
|
| 138 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028474">NO</rx:tx_on_clinical_trial>
|
| 139 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 140 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DU-A76L-D50324</rx:bcr_drug_barcode>
|
| 141 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">D3A914AA-DC46-4157-98C9-D4F975FFD86B</rx:bcr_drug_uuid>
|
| 142 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 143 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 144 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 145 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 146 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 147 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">54</rx:days_to_drug_therapy_start>
|
| 148 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">406</rx:days_to_drug_therapy_end>
|
| 149 |
+
<rx:therapy_types>
|
| 150 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028477">Chemotherapy</rx:therapy_type>
|
| 151 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 152 |
+
</rx:therapy_types>
|
| 153 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028475">Temozolomide</rx:drug_name>
|
| 154 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028476"/>
|
| 155 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 156 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 157 |
+
<rx:route_of_administrations>
|
| 158 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 159 |
+
</rx:route_of_administrations>
|
| 160 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028482">NO</rx:therapy_ongoing>
|
| 161 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028487">Clinical Progressive Disease</clin_shared:measure_of_response>
|
| 162 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">22</clin_shared:day_of_form_completion>
|
| 163 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 164 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 165 |
+
</rx:drug>
|
| 166 |
+
<rx:drug>
|
| 167 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028862">YES</rx:tx_on_clinical_trial>
|
| 168 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 169 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DU-A76L-D50331</rx:bcr_drug_barcode>
|
| 170 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">225CBF1C-33B0-428A-9718-F9F4236532BA</rx:bcr_drug_uuid>
|
| 171 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 172 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 173 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 174 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 175 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 176 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">588</rx:days_to_drug_therapy_start>
|
| 177 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">617</rx:days_to_drug_therapy_end>
|
| 178 |
+
<rx:therapy_types>
|
| 179 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028865">Chemotherapy</rx:therapy_type>
|
| 180 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 181 |
+
</rx:therapy_types>
|
| 182 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028863">Procarbazine</rx:drug_name>
|
| 183 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028864"/>
|
| 184 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 185 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 186 |
+
<rx:route_of_administrations>
|
| 187 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 188 |
+
</rx:route_of_administrations>
|
| 189 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028870">NO</rx:therapy_ongoing>
|
| 190 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028875">Clinical Progressive Disease</clin_shared:measure_of_response>
|
| 191 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">22</clin_shared:day_of_form_completion>
|
| 192 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 193 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 194 |
+
</rx:drug>
|
| 195 |
+
<rx:drug>
|
| 196 |
+
<rx:tx_on_clinical_trial preferred_name="" display_order="9999" cde="3925111" cde_ver="" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028879">YES</rx:tx_on_clinical_trial>
|
| 197 |
+
<rx:regimen_number preferred_name="" display_order="9999" cde="2744948" cde_ver="" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 198 |
+
<rx:bcr_drug_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DU-A76L-D50332</rx:bcr_drug_barcode>
|
| 199 |
+
<rx:bcr_drug_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">6ACA75BD-AD14-4501-9992-FF1E76A48199</rx:bcr_drug_uuid>
|
| 200 |
+
<rx:total_dose preferred_name="total_dose" display_order="999" cde="1515" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 201 |
+
<rx:total_dose_units preferred_name="pharmaceutical_tx_total_dose_units" display_order="999" cde="3088785" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 202 |
+
<rx:prescribed_dose preferred_name="prescribed_dose" display_order="999" cde="2184728" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 203 |
+
<rx:prescribed_dose_units preferred_name="pharmaceutical_tx_dose_units" display_order="999" cde="3065815" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 204 |
+
<rx:number_cycles preferred_name="pharma_adjuvant_cycles_count" display_order="999" cde="62590" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 205 |
+
<rx:days_to_drug_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3392465" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_started_days_to" display_order="26" cde_ver="1.000">651</rx:days_to_drug_therapy_start>
|
| 206 |
+
<rx:days_to_drug_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3392470" owner="TSS" procurement_status="Completed" preferred_name="pharmaceutical_tx_ended_days_to" display_order="16" cde_ver="1.000">732</rx:days_to_drug_therapy_end>
|
| 207 |
+
<rx:therapy_types>
|
| 208 |
+
<rx:therapy_type preferred_name="pharmaceutical_therapy_type" display_order="7" cde="2793530" cde_ver="1.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028882">Targeted Molecular therapy</rx:therapy_type>
|
| 209 |
+
<rx:therapy_type_notes preferred_name="pharma_type_other" display_order="999" cde="2001762" cde_ver="4.000" xsd_ver="2.1" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 210 |
+
</rx:therapy_types>
|
| 211 |
+
<rx:drug_name preferred_name="pharmaceutical_therapy_drug_name" display_order="22" cde="2975232" cde_ver="1.000" xsd_ver="1.10" tier="1" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028880">Cilengtide</rx:drug_name>
|
| 212 |
+
<rx:clinical_trail_drug_classification preferred_name="clinical_trial_drug_classification" display_order="6" cde="3378323" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Not Available" restricted="false" source_system_identifier="3028881"/>
|
| 213 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 214 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 215 |
+
<rx:route_of_administrations>
|
| 216 |
+
<rx:route_of_administration preferred_name="route_of_administration" display_order="999" cde="2003586" cde_ver="6.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 217 |
+
</rx:route_of_administrations>
|
| 218 |
+
<rx:therapy_ongoing preferred_name="pharmaceutical_tx_ongoing_indicator" display_order="12" cde="3103479" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028887">NO</rx:therapy_ongoing>
|
| 219 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028892">Clinical Progressive Disease</clin_shared:measure_of_response>
|
| 220 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">22</clin_shared:day_of_form_completion>
|
| 221 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 222 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 223 |
+
</rx:drug>
|
| 224 |
+
</rx:drugs>
|
| 225 |
+
<rad:radiations>
|
| 226 |
+
<rad:radiation>
|
| 227 |
+
<rad:bcr_radiation_barcode xsd_ver="1.15" owner="TSS" procurement_status="Completed" restricted="false">TCGA-DU-A76L-R50322</rad:bcr_radiation_barcode>
|
| 228 |
+
<rad:bcr_radiation_uuid preferred_name="" display_order="9999" cde="" cde_ver="" xsd_ver="2.3" owner="TSS" procurement_status="Completed" restricted="false">535FF4EB-212C-4AD2-8AE7-37C121D9891E</rad:bcr_radiation_uuid>
|
| 229 |
+
<rad:days_to_radiation_therapy_start precision="day" xsd_ver="1.12" tier="2" cde="3008313" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_started_days_to" display_order="33" cde_ver="1.000">16</rad:days_to_radiation_therapy_start>
|
| 230 |
+
<rad:days_to_radiation_therapy_end precision="day" xsd_ver="1.12" tier="2" cde="3008333" owner="TSS" procurement_status="Completed" preferred_name="radiation_therapy_ended_days_to" display_order="17" cde_ver="1.000">57</rad:days_to_radiation_therapy_end>
|
| 231 |
+
<rad:radiation_type preferred_name="radiation_therapy_type" display_order="4" cde="2842944" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028419">External</rad:radiation_type>
|
| 232 |
+
<rad:radiation_type_notes preferred_name="radiation_type_other" display_order="999" cde="2195477" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Applicable" restricted="false"/>
|
| 233 |
+
<rad:radiation_dosage preferred_name="radiation_total_dose" display_order="6" cde="2721441" cde_ver="1.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028421">60</rad:radiation_dosage>
|
| 234 |
+
<rad:units preferred_name="radiation_adjuvant_units" display_order="7" cde="61446" cde_ver="3.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028422">Gy</rad:units>
|
| 235 |
+
<rad:numfractions preferred_name="radiation_adjuvant_fractions_total" display_order="8" cde="61465" cde_ver="3.000" xsd_ver="1.8" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028423">30</rad:numfractions>
|
| 236 |
+
<rad:anatomic_treatment_site preferred_name="radiation_therapy_site" display_order="5" cde="2793522" cde_ver="1.000" xsd_ver="2.3" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028420">Primary Tumor Field</rad:anatomic_treatment_site>
|
| 237 |
+
<clin_shared:regimen_indication preferred_name="therapy_regimen" display_order="999" cde="2793511" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 238 |
+
<clin_shared:regimen_indication_notes preferred_name="therapy_regimen_other" display_order="999" cde="2793516" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 239 |
+
<rad:radiation_treatment_ongoing preferred_name="radiation_therapy_ongoing_indicator" display_order="13" cde="2842745" cde_ver="1.000" xsd_ver="1.12" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028428">NO</rad:radiation_treatment_ongoing>
|
| 240 |
+
<rad:course_number preferred_name="course_number" display_order="999" cde="2732184" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Not Available" restricted="false"/>
|
| 241 |
+
<clin_shared:measure_of_response preferred_name="treatment_best_response" display_order="17" cde="2857291" cde_ver="1.000" xsd_ver="2.5" tier="2" owner="TSS" procurement_status="Completed" restricted="false" source_system_identifier="3028433">Stable Disease</clin_shared:measure_of_response>
|
| 242 |
+
<clin_shared:day_of_form_completion preferred_name="form_completion_day" display_order="999" cde="2975716" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">22</clin_shared:day_of_form_completion>
|
| 243 |
+
<clin_shared:month_of_form_completion preferred_name="form_completion_month" display_order="999" cde="2975718" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">10</clin_shared:month_of_form_completion>
|
| 244 |
+
<clin_shared:year_of_form_completion preferred_name="form_completion_year" display_order="999" cde="2975720" cde_ver="1.000" xsd_ver="2.2" tier="2" owner="TSS" procurement_status="Completed" restricted="false">2013</clin_shared:year_of_form_completion>
|
| 245 |
+
</rad:radiation>
|
| 246 |
+
</rad:radiations>
|
| 247 |
+
<lgg:follow_ups/>
|
| 248 |
+
</lgg:patient>
|
| 249 |
+
</lgg:tcga_bcr>
|